{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:44:15Z","timestamp":1793472255982,"version":"4.5.0"},"reference-count":382,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T00:00:00Z","timestamp":1453420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12035-015-9672-6","type":"journal-article","created":{"date-parts":[[2016,1,22]],"date-time":"2016-01-22T02:30:25Z","timestamp":1453429825000},"page":"1046-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":345,"title":["Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery"],"prefix":"10.1007","volume":"54","author":[{"given":"Simon G.","family":"Patching","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,22]]},"reference":[{"issue":"7","key":"9672_CR1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1088\/0034-4885\/64\/7\/202","volume":"64","author":"C Nicholson","year":"2001","unstructured":"Nicholson C (2001) Diffusion and related transport mechanisms in brain tissue. Rep Prog Phys 64(7):815\u2013884","journal-title":"Rep Prog Phys"},{"issue":"4","key":"9672_CR2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1568026013395100","volume":"1","author":"A Avdeef","year":"2001","unstructured":"Avdeef A (2001) Physicochemical profiling (solubility, permeability and charge state). Curr Top Med Chem 1(4):277\u2013351","journal-title":"Curr Top Med Chem"},{"issue":"1\u20133","key":"9672_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"9672_CR4","doi-asserted-by":"crossref","first-page":"218S","DOI":"10.1093\/jn\/136.1.218S","volume":"136","author":"RA Hawkins","year":"2006","unstructured":"Hawkins RA, O'Kane RL, Simpson IA, Vi\u00f1a JR (2006) Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 136(1):218S\u2013226S","journal-title":"J Nutr"},{"issue":"2","key":"9672_CR5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57(2):178\u2013201","journal-title":"Neuron"},{"issue":"4","key":"9672_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-009-0177-0","volume":"31","author":"B Engelhardt","year":"2009","unstructured":"Engelhardt B, Sorokin L (2009) The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 31(4):497\u2013511","journal-title":"Semin Immunopathol"},{"issue":"1","key":"9672_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37(1):13\u201325","journal-title":"Neurobiol Dis"},{"issue":"1","key":"9672_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z (2011) Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8(1):3","journal-title":"Fluids Barriers CNS"},{"key":"9672_CR9","first-page":"7","volume":"6","author":"AD Wong","year":"2013","unstructured":"Wong AD, Ye M, Levy AF, Rothstein JD, Bergles DE, Searson PC (2013) The blood-brain barrier: an engineering perspective. Front Neuroeng 6:7","journal-title":"Front Neuroeng"},{"issue":"10","key":"9672_CR10","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2174\/13816128113199990463","volume":"20","author":"L Sanchez-Covarrubias","year":"2014","unstructured":"Sanchez-Covarrubias L, Slosky LM, Thompson BJ, Davis TP, Ronaldson PT (2014) Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? Curr Pharm Des 20(10):1422\u20131449","journal-title":"Curr Pharm Des"},{"issue":"21","key":"9672_CR11","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","volume":"282","author":"J Keaney","year":"2015","unstructured":"Keaney J, Campbell M (2015) The dynamic blood-brain barrier. FEBS J 282(21):4067\u20134079","journal-title":"FEBS J"},{"issue":"7","key":"9672_CR12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/sj.jcbfm.9600249","volume":"26","author":"BE Enerson","year":"2006","unstructured":"Enerson BE, Drewes LR (2006) The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 26(7):959\u2013973","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"9672_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1023\/A:1007518525161","volume":"17","author":"Y Kido","year":"2000","unstructured":"Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A (2000) Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res 17(1):55\u201362","journal-title":"Pharm Res"},{"issue":"1","key":"9672_CR14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, Bell RD, Sagare A, Zlokovic BV (2009) Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 8(1):16\u201330","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"12","key":"9672_CR15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12(12):723\u2013738","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"9672_CR16","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 32(11):1959\u20131972","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"9672_CR17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks WA, Owen JB, Erickson MA (2012) Insulin in the brain: there and back again. Pharmacol Ther 136(1):82\u201393","journal-title":"Pharmacol Ther"},{"issue":"2","key":"9672_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","volume":"211","author":"N Bien-Ly","year":"2014","unstructured":"Bien-Ly N, Yu YJ, Bumbaca D, Elstrott J, Boswell CA, Zhang Y, Luk W, Lu Y et al (2014) Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants. J Exp Med 211(2):233\u2013244","journal-title":"J Exp Med"},{"key":"9672_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnins.2015.00021","volume":"9","author":"N Strazielle","year":"2015","unstructured":"Strazielle N, Ghersi-Egea JF (2015) Efflux transporters in blood-brain interfaces of the developing brain. Front Neurosci 9:21","journal-title":"Front Neurosci"},{"issue":"4","key":"9672_CR20","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1210\/en.2014-1830","volume":"156","author":"G Wittmann","year":"2015","unstructured":"Wittmann G, Szabon J, Moh\u00e1csik P, Nouriel SS, Gereben B, Fekete C, Lechan RM (2015) Parallel regulation of thyroid hormone transporters OATP1c1 and MCT8 during and after endotoxemia at the blood-brain barrier of male rodents. Endocrinology 156(4):1552\u20131564","journal-title":"Endocrinology"},{"issue":"36","key":"9672_CR21","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.1323099111","volume":"111","author":"CW Kuzawa","year":"2014","unstructured":"Kuzawa CW, Chugani HT, Grossman LI, Lipovich L, Muzik O, Hof PR, Wildman DE, Sherwood CC et al (2014) Metabolic costs and evolutionary implications of human brain development. Proc Natl Acad Sci U S A 111(36):13010\u201313015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"9672_CR22","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/WNL.0000000000000328","volume":"82","author":"EE Benarroch","year":"2014","unstructured":"Benarroch EE (2014) Brain glucose transporters: implications for neurologic disease. Neurology 82(15):1374\u20131379","journal-title":"Neurology"},{"issue":"22","key":"9672_CR23","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1073\/pnas.81.22.7233","volume":"81","author":"APK Dick","year":"1984","unstructured":"Dick APK, Harik SI, Klip A, Walker DM (1984) Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci U S A 81(22):7233\u20137237","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9672_CR24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/09687680110090456","volume":"18","author":"HG Joost","year":"2001","unstructured":"Joost HG, Thorens B (2001) The extended GLUT-family of sugar\/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 18(4):247\u2013256","journal-title":"Mol Membr Biol"},{"issue":"5","key":"9672_CR25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00424-003-1085-0","volume":"447","author":"M Uldry","year":"2004","unstructured":"Uldry M, Thorens B (2004) The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447(5):480\u2013489","journal-title":"Pflugers Arch"},{"issue":"2","key":"9672_CR26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/138920207780368187","volume":"8","author":"FQ Zhao","year":"2007","unstructured":"Zhao FQ, Keating AF (2007) Functional properties and genomics of glucose transporters. Curr Genomics 8(2):113\u2013128","journal-title":"Curr Genomics"},{"key":"9672_CR27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1152\/physiol.00011.2007","volume":"22","author":"AR Manolescu","year":"2007","unstructured":"Manolescu AR, Witkowska K, Kinnaird A, Cessford T, Cheeseman C (2007) Facilitated hexose transporters: new perspectives on form and function. Physiology (Bethesda) 22:234\u2013240","journal-title":"Physiology (Bethesda)"},{"issue":"4","key":"9672_CR28","doi-asserted-by":"crossref","first-page":"E836","DOI":"10.1152\/ajpendo.00496.2009","volume":"297","author":"A Carruthers","year":"2009","unstructured":"Carruthers A, DeZutter J, Ganguly A, Devaskar SU (2009) Will the original glucose transporter isoform please stand up! Am J Physiol Endocrinol Metab 297(4):E836\u2013E848","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"9672_CR29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/iub.315","volume":"62","author":"R Augustin","year":"2010","unstructured":"Augustin R (2010) The protein family of glucose transport facilitators: it's not only about glucose after all. IUBMB Life 62(5):315\u2013333","journal-title":"IUBMB Life"},{"issue":"2","key":"9672_CR30","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens B, Mueckler M (2010) Glucose transporters in the 21st century. Am J Physiol Endocrinol Metab 298(2):E141\u2013E145","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"9672_CR31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/cphy.c110024","volume":"2","author":"AJ Cura","year":"2012","unstructured":"Cura AJ, Carruthers A (2012) Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis. Compr Physiol 2(2):863\u2013914","journal-title":"Compr Physiol"},{"issue":"2\u20133","key":"9672_CR32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","volume":"34","author":"M Mueckler","year":"2013","unstructured":"Mueckler M, Thorens B (2013) The SLC2 (GLUT) family of membrane transporters. Mol Asp Med 34(2\u20133):121\u2013138","journal-title":"Mol Asp Med"},{"issue":"7","key":"9672_CR33","doi-asserted-by":"crossref","first-page":"E719","DOI":"10.1073\/pnas.1400336111","volume":"111","author":"MG Madej","year":"2014","unstructured":"Madej MG, Sun L, Yan N, Kaback HR (2014) Functional architecture of MFS D-glucose transporters. Proc Natl Acad Sci U S A 111(7):E719\u2013E727","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9672_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","volume":"62","author":"SS Pao","year":"1998","unstructured":"Pao SS, Paulsen IT, Saier MH Jr (1998) Major facilitator superfamily. Microbiol Mol Biol Rev 62(1):1\u201334","journal-title":"Microbiol Mol Biol Rev"},{"issue":"2","key":"9672_CR35","first-page":"257","volume":"1","author":"MH Saier Jr","year":"1999","unstructured":"Saier MH Jr, Beatty JT, Goffeau A, Harley KT, Heijne WH, Huang SC, Jack DL, J\u00e4hn PS et al (1999) The major facilitator superfamily. J Mol Microbiol Biotechnol 1(2):257\u2013279","journal-title":"J Mol Microbiol Biotechnol"},{"issue":"111","key":"9672_CR36","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1742-4658.2012.08588.x","volume":"279","author":"VS Reddy","year":"2012","unstructured":"Reddy VS, Shlykov MA, Castillo R, Sun EI, Saier MH Jr (2012) The major facilitator superfamily (MFS) revisited. FEBS J 279(111):2022\u20132035","journal-title":"FEBS J"},{"issue":"44","key":"9672_CR37","doi-asserted-by":"crossref","first-page":"17862","DOI":"10.1073\/pnas.1311485110","volume":"110","author":"CV Iancu","year":"2013","unstructured":"Iancu CV, Zamoon J, Woo SB, Aleshin A, Choe JY (2013) Crystal structure of a glucose\/H+ symporter and its mechanism of action. Proc Natl Acad Sci U S A 110(44):17862\u201317867","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9672_CR38","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","volume":"91","author":"EM Wright","year":"2011","unstructured":"Wright EM, Loo DD, Hirayama BA (2011) Biology of human sodium glucose transporters. Physiol Rev 91(2):733\u2013794","journal-title":"Physiol Rev"},{"issue":"2\u20133","key":"9672_CR39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mam.2012.11.002","volume":"34","author":"EM Wright","year":"2013","unstructured":"Wright EM (2013) Glucose transport families SLC5 and SLC50. Mol Asp Med 34(2\u20133):183\u2013196","journal-title":"Mol Asp Med"},{"issue":"20","key":"9672_CR40","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1016\/S0021-9258(19)66976-0","volume":"252","author":"M Kasahara","year":"1997","unstructured":"Kasahara M, Hinkle PC (1997) Reconstitution and purification of the D-glucose transporter from human erythrocytes. J Biol Chem 252(20):7384\u20137390","journal-title":"J Biol Chem"},{"issue":"19","key":"9672_CR41","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1016\/S0021-9258(17)38008-0","volume":"253","author":"MA Zoccoli","year":"1978","unstructured":"Zoccoli MA, Baldwin SA, Lienhard GE (1978) The monosaccharide transport system of the human erythrocyte. Solubilization and characterization on the basis of cytochalasin B binding. J Biol Chem 253(19):6923\u20136930","journal-title":"J Biol Chem"},{"issue":"4717","key":"9672_CR42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1126\/science.3839598","volume":"229","author":"M Mueckler","year":"1985","unstructured":"Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE et al (1985) Sequence and structure of a human glucose transporter. Science 229(4717):941\u2013945","journal-title":"Science"},{"key":"9672_CR43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0076-6879(89)74008-8","volume":"174","author":"SA Baldwin","year":"1989","unstructured":"Baldwin SA, Lienhard GE (1989) Purification and reconstitution of glucose transporter from human erythrocytes. Methods Enzymol 174:39\u201350","journal-title":"Methods Enzymol"},{"issue":"7503","key":"9672_CR44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature13306","volume":"510","author":"D Deng","year":"2014","unstructured":"Deng D, Xu C, Sun P, Wu J, Yan C, Hu M, Yan N (2014) Crystal structure of the human glucose transporter GLUT1. Nature 510(7503):121\u2013125","journal-title":"Nature"},{"issue":"7420","key":"9672_CR45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11524","volume":"490","author":"L Sun","year":"2012","unstructured":"Sun L, Zeng X, Yan C, Sun X, Gong X, Rao Y, Yan N (2012) Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature 490(7420):361\u2013366","journal-title":"Nature"},{"issue":"2","key":"9672_CR46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj1310211","volume":"131","author":"JE Barnett","year":"1973","unstructured":"Barnett JE, Holman GD, Munday KA (1973) Structural requirements for binding to the sugar transport system of the human erythrocyte. Biochem J 131(2):211\u2013221","journal-title":"Biochem J"},{"issue":"1","key":"9672_CR47","doi-asserted-by":"crossref","first-page":"C151","DOI":"10.1152\/ajpcell.00359.2008","volume":"296","author":"JM Leitch","year":"2009","unstructured":"Leitch JM, Carruthers A (2009) Alpha- and beta-monosaccharide transport in human erythrocytes. Am J Physiol Cell Physiol 296(1):C151\u2013C161","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"9672_CR48","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0005-2736(86)90342-1","volume":"857","author":"AG Lowe","year":"1986","unstructured":"Lowe AG, Walmsley AR (1986) The kinetics of glucose transport in human red blood cells. Biochim Biophys Acta 857(2):146\u2013154","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"9672_CR49","doi-asserted-by":"crossref","first-page":"8907","DOI":"10.1016\/S0021-9258(19)52485-1","volume":"256","author":"TJ Wheeler","year":"1981","unstructured":"Wheeler TJ, Hinkle PC (1981) Kinetic properties of the reconstituted glucose transporter from human erythrocytes. J Biol Chem 256(17):8907\u20138914","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"9672_CR50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0005-2736(98)00170-9","volume":"1414","author":"TJ Wheeler","year":"1998","unstructured":"Wheeler TJ, Cole D, Hauck MA (1998) Characterization of glucose transport activity reconstituted from heart and other tissues. Biochim Biophys Acta 1414(1\u20132):217\u2013230","journal-title":"Biochim Biophys Acta"},{"issue":"32","key":"9672_CR51","doi-asserted-by":"crossref","first-page":"18884","DOI":"10.1016\/S0021-9258(19)47239-6","volume":"264","author":"K Keller","year":"1989","unstructured":"Keller K, Strube M, Mueckler M (1989) Functional expression of the human HepG2 and rat adipocyte glucose transporters in Xenopus oocytes. Comparison of kinetic parameters. J Biol Chem 264(32):18884\u201318889","journal-title":"J Biol Chem"},{"issue":"24","key":"9672_CR52","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1021\/bi00450a030","volume":"28","author":"GW Gould","year":"1989","unstructured":"Gould GW, Lienhard GE (1989) Expression of a functional glucose transporter in Xenopus oocytes. Biochemistry 28(24):9447\u20139452","journal-title":"Biochemistry"},{"issue":"10","key":"9672_CR53","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1128\/MCB.9.10.4187","volume":"9","author":"JC Vera","year":"1989","unstructured":"Vera JC, Rosen OM (1989) Functional expression of mammalian glucose transporters in Xenopus laevis oocytes: evidence for cell-dependent insulin sensitivity. Mol Cell Biol 9(10):4187\u20134195","journal-title":"Mol Cell Biol"},{"issue":"12","key":"9672_CR54","doi-asserted-by":"crossref","first-page":"8514","DOI":"10.1016\/S0021-9258(18)52905-7","volume":"268","author":"H Nishimura","year":"1993","unstructured":"Nishimura H, Pallardo FV, Seidner GA, Vannucci S, Simpson IA, Birnbaum MJ (1993) Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem 268(12):8514\u20138520","journal-title":"J Biol Chem"},{"issue":"32","key":"9672_CR55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/364079a0","volume":"364","author":"JC Vera","year":"1993","unstructured":"Vera JC, Rivas CI, Fischbarg J, Golde DW (1993) Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid. Nature 364(32):79\u201382","journal-title":"Nature"},{"issue":"10","key":"9672_CR56","doi-asserted-by":"crossref","first-page":"C910","DOI":"10.1152\/ajpcell.00044.2014","volume":"306","author":"JM Sage","year":"2014","unstructured":"Sage JM, Carruthers A (2014) Human erythrocytes transport dehydroascorbic acid and sugars using the same transporter complex. Am J Physiol Cell Physiol 306(10):C910\u2013C917","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"9672_CR57","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1096\/fj.05-4107com","volume":"19","author":"S KC","year":"2005","unstructured":"KC S, C\u00e1rcamo JM, Golde DW (2005) Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J 19(12):1657\u20131667","journal-title":"FASEB J"},{"issue":"3","key":"9672_CR58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1039\/B920471G","volume":"2","author":"X Jiang","year":"2010","unstructured":"Jiang X, McDermott JR, Ajees AA, Rosen BP, Liu Z (2010) Trivalent arsenicals and glucose use different translocation pathways in mammalian GLUT1. Metallomics 2(3):211\u2013219","journal-title":"Metallomics"},{"issue":"1","key":"9672_CR59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.17229\/jdit.2015-0301-014","volume":"2","author":"SG Patching","year":"2015","unstructured":"Patching SG (2015) Roles of facilitative glucose transporter GLUT1 in [18F]FDG positron emission tomography (PET) imaging of human diseases. J Diagn Imaging Ther 2(1):30\u2013102","journal-title":"J Diagn Imaging Ther"},{"issue":"23","key":"9672_CR60","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1021\/bi00747a036","volume":"12","author":"R Bloch","year":"1973","unstructured":"Bloch R (1973) Inhibition of glucose transport in the human erythrocyte by cytochalasin B. Biochemistry 12(23):4799\u20134801","journal-title":"Biochemistry"},{"key":"9672_CR61","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1113\/jphysiol.1978.sp012311","volume":"278","author":"DA Basketter","year":"1978","unstructured":"Basketter DA, Widdas WF (1978) Asymmetry of the hexose transfer system in human erythrocytes. Comparison of the effects of cytochalasin B, phloretin and maltose as competitive inhibitors. J Physiol 278:389\u2013401","journal-title":"J Physiol"},{"issue":"27","key":"9672_CR62","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1016\/S0021-9258(17)38624-6","volume":"260","author":"S Sergeant","year":"1985","unstructured":"Sergeant S, Kim HD (1985) Inhibition of 3-O-methylglucose transport in human erythrocytes by forskolin. J Biol Chem 260(27):14677\u201314682","journal-title":"J Biol Chem"},{"issue":"3","key":"9672_CR63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cbi.2003.06.001","volume":"146","author":"HJ Martin","year":"2003","unstructured":"Martin HJ, Kornmann F, Fuhrmann GF (2003) The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. Chem Biol Interact 146(3):225\u2013235","journal-title":"Chem Biol Interact"},{"issue":"15","key":"9672_CR64","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1021\/bi1020327","volume":"50","author":"T Robichaud","year":"2011","unstructured":"Robichaud T, Appleyard AN, Herbert RB, Henderson PJ, Carruthers A (2011) Determinants of ligand binding affinity and cooperativity at the GLUT1 endofacial site. Biochemistry 50(15):3137\u20133148","journal-title":"Biochemistry"},{"issue":"13","key":"9672_CR65","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1073\/pnas.88.13.5779","volume":"88","author":"CL Farrell","year":"1991","unstructured":"Farrell CL, Pardridge WM (1991) Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci U S A 88(13):5779\u20135783","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9672_CR66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15216540214541","volume":"54","author":"RA Hawkins","year":"2002","unstructured":"Hawkins RA, Peterson DR, Vi\u00f1a JR (2002) The complementary membranes forming the blood-brain barrier. IUBMB Life 54(3):101\u2013107","journal-title":"IUBMB Life"},{"issue":"4","key":"9672_CR67","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jnr.490220413","volume":"22","author":"DZ Gerhart","year":"1989","unstructured":"Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR (1989) Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res 22(4):464\u2013472","journal-title":"J Neurosci Res"},{"issue":"1","key":"9672_CR68","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/jcbfm.1994.15","volume":"14","author":"EM Cornford","year":"1994","unstructured":"Cornford EM, Hyman S, Swartz BE (1994) The human brain glut1 glucose transporter: ultrastructural localization to the blood-brain barrier endothelia. J Cereb Blood Flow Metab 14(1):106\u2013112","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"9672_CR69","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0006-8993(00)01942-9","volume":"858","author":"R Duelli","year":"2000","unstructured":"Duelli R, Maurer MH, Staudt R, Heiland S, Duembgen L, Kuschinsky W (2000) Increased cerebral glucose utilization and decreased glucose transporter Glut1 during chronic hyperglycemia in rat brain. Brain Res 858(2):338\u2013347","journal-title":"Brain Res"},{"key":"9672_CR70","first-page":"71","volume":"16","author":"R Duelli","year":"2001","unstructured":"Duelli R, Kuschinsky W (2001) Brain glucose transporters: relationship to local energy demand. News Physiol Sci 16:71\u201376","journal-title":"News Physiol Sci"},{"issue":"1","key":"9672_CR71","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(01)02418-0","volume":"904","author":"MS McAllister","year":"2001","unstructured":"McAllister MS, Krizanac-Bengez L, Macchia F, Naftalin RJ, Pedley KC, Mayberg MR, Marroni M, Leaman S et al (2001) Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain Res 904(1):20\u201330","journal-title":"Brain Res"},{"issue":"16","key":"9672_CR72","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1074\/jbc.M010897200","volume":"276","author":"IA Simpson","year":"2001","unstructured":"Simpson IA, Vannucci SJ, DeJoseph MR, Hawkins RA (2001) Glucose transporter asymmetries in the bovine blood-brain barrier. J Biol Chem 276(16):12725\u201312729","journal-title":"J Biol Chem"},{"issue":"1","key":"9672_CR73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1602\/neurorx.2.1.27","volume":"2","author":"EM Cornford","year":"2005","unstructured":"Cornford EM, Hyman S (2005) Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx 2(1):27\u201343","journal-title":"NeuroRx"},{"issue":"9","key":"9672_CR74","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1002\/jps.24398","volume":"104","author":"Y Kubo","year":"2015","unstructured":"Kubo Y, Ohtsuki S, Uchida Y, Terasaki T (2015) Quantitative determination of luminal and abluminal membrane distributions of transporters in porcine brain capillaries by plasma membrane fractionation and quantitative targeted proteomics. J Pharm Sci 104(9):3060\u20133068","journal-title":"J Pharm Sci"},{"issue":"12","key":"9672_CR75","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/jnr.22738","volume":"89","author":"K Devraj","year":"2011","unstructured":"Devraj K, Klinger ME, Myers RL, Mokashi A, Hawkins RA, Simpson IA (2011) GLUT-1 glucose transporters in the blood-brain barrier: differential phosphorylation. J Neurosci Res 89(12):1913\u20131925","journal-title":"J Neurosci Res"},{"issue":"12","key":"9672_CR76","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/glia.20375","volume":"55","author":"LF Barros","year":"2007","unstructured":"Barros LF, Bittner CX, Loaiza A, Porras OH (2007) A quantitative overview of glucose dynamics in the gliovascular unit. Glia 55(12):1222\u20131237","journal-title":"Glia"},{"issue":"8","key":"9672_CR77","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00018-012-1219-7","volume":"70","author":"M Kreft","year":"2013","unstructured":"Kreft M, Luk\u0161i\u010d M, Zorec TM, Prebil M, Zorec R (2013) Diffusion of D-glucose measured in the cytosol of a single astrocyte. Cell Mol Life Sci 70(8):1483\u20131492","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"9672_CR78","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1152\/physrev.1983.63.4.1481","volume":"63","author":"WM Pardridge","year":"1983","unstructured":"Pardridge WM (1983) Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 63(4):1481\u20131535","journal-title":"Physiol Rev"},{"issue":"1","key":"9672_CR79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0969-2126(98)00006-9","volume":"6","author":"AE Aleshin","year":"1998","unstructured":"Aleshin AE, Zeng C, Bourenkov GP, Bartunik HD, Fromm HJ, Honzatko RB (1998) The mechanism of regulation of hexokinase: new insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate. Structure 6(1):39\u201350","journal-title":"Structure"},{"issue":"2","key":"9672_CR80","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1152\/physrev.1979.59.2.305","volume":"59","author":"H Lund-Andersen","year":"1979","unstructured":"Lund-Andersen H (1979) Transport of glucose from blood to brain. Physiol Rev 59(2):305\u2013352","journal-title":"Physiol Rev"},{"issue":"4","key":"9672_CR81","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-201X.1998.t01-1-00360.x","volume":"163","author":"G Blomqvist","year":"1998","unstructured":"Blomqvist G, Grill V, Ingvar M, Wid\u00e9n L, Stone-Elander S (1998) The effect of hyperglycaemia on regional cerebral glucose oxidation in humans studied with [1-11C]-D-glucose. Acta Physiol Scand 163(4):403\u2013415","journal-title":"Acta Physiol Scand"},{"issue":"3","key":"9672_CR82","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1073\/pnas.89.3.1109","volume":"89","author":"R Gruetter","year":"1992","unstructured":"Gruetter R, Novotny EJ, Boulware SD, Rothman DL, Mason GF, Shulman GI, Shulman RG, Tamborlane WV (1992) Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proc Natl Acad Sci U S A 89(3):1109\u20131112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9672_CR83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1471-4159.1998.70010397.x","volume":"70","author":"R Gruetter","year":"1998","unstructured":"Gruetter R, Ugurbil K, Seaquist ER (1998) Steady-state cerebral glucose concentrations and transport in the human brain. J Neurochem 70(1):397\u2013408","journal-title":"J Neurochem"},{"issue":"2","key":"9672_CR84","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1471-4159.1999.720785.x","volume":"72","author":"EC McNay","year":"1999","unstructured":"McNay EC, Gold PE (1999) Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: effects of microdialysis flow rate, strain, and age. J Neurochem 72(2):785\u2013790","journal-title":"J Neurochem"},{"issue":"3","key":"9672_CR85","first-page":"701","volume":"47","author":"P Reinstrup","year":"2000","unstructured":"Reinstrup P, Stahl N, Mellergard P, Uski T, Ungerstedt U, Nordstrom CH (2000) Intracerebral microdialysis in clinical practice: baseline values for chemical markers during wakefulness, anesthesia, and neurosurgery. Neurosurgery 47(3):701\u2013709","journal-title":"Neurosurgery"},{"key":"9672_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-152816-4.50005-4","volume":"16","author":"JE Wilson","year":"1980","unstructured":"Wilson JE (1980) Brain hexokinase, the prototype ambiquitous enzyme. Curr Top Cell Regul 16:1\u201354","journal-title":"Curr Top Cell Regul"},{"issue":"3","key":"9672_CR87","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0163-7258(95)00007-4","volume":"66","author":"KM McGowan","year":"1995","unstructured":"McGowan KM, Long SD, Pekala PH (1995) Glucose transporter gene expression: regulation of transcription and mRNA stability. Pharmacol Ther 66(3):465\u2013505","journal-title":"Pharmacol Ther"},{"issue":"2","key":"9672_CR88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1471-4159.1996.66020449.x","volume":"66","author":"KJ Dwyer","year":"1996","unstructured":"Dwyer KJ, Boado RJ, Pardridge WM (1996) Cis-element\/cytoplasmic protein interaction within the 3'-untranslated region of the glut1 glucose transporter mRNA. J Neurochem 66(2):449\u2013458","journal-title":"J Neurochem"},{"issue":"3","key":"9672_CR89","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1210\/endo-129-3-1530","volume":"129","author":"S Devaskar","year":"1991","unstructured":"Devaskar S, Zahm DS, Holtzclaw L, Chundu K, Wadzinski BE (1991) Developmental regulation of the distribution of rat brain insulin-insensitive (Glut 1) glucose transporter. Endocrinology 129(3):1530\u20131540","journal-title":"Endocrinology"},{"issue":"1","key":"9672_CR90","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/diab.42.1.80","volume":"42","author":"N Kaiser","year":"1993","unstructured":"Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ et al (1993) Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 42(1):80\u201389","journal-title":"Diabetes"},{"issue":"6","key":"9672_CR91","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ana.22318","volume":"68","author":"PP Zheng","year":"2010","unstructured":"Zheng PP, Romme E, van der Spek PJ, Dirven CM, Willemsen R, Kros JM (2010) Glut1\/SLC2A1 is crucial for the development of the blood-brain barrier in vivo. Ann Neurol 68(6):835\u2013844","journal-title":"Ann Neurol"},{"issue":"2","key":"9672_CR92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00926756","volume":"140","author":"SJ Vannucci","year":"1994","unstructured":"Vannucci SJ, Seaman LB, Brucklacher RM, Vannucci RC (1994) Glucose transport in developing rat brain: glucose transporter proteins, rate constants and cerebral glucose utilization. Mol Cell Biochem 140(2):177\u2013184","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"9672_CR93","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(99)01078-1","volume":"824","author":"F Nualart","year":"1999","unstructured":"Nualart F, Godoy A, Reinicke K (1999) Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain. Brain Res 824(1):97\u2013104","journal-title":"Brain Res"},{"issue":"1","key":"9672_CR94","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-3806(00)00086-9","volume":"123","author":"D Virgintino","year":"2000","unstructured":"Virgintino D, Robertson D, Benagiano V, Errede M, Bertossi M, Ambrosi G, Roncali L (2000) Immunogold cytochemistry of the blood-brain barrier glucose transporter GLUT1 and endogenous albumin in the developing human brain. Brain Res Dev Brain Res 123(1):95\u2013101","journal-title":"Brain Res Dev Brain Res"},{"issue":"5","key":"9672_CR95","doi-asserted-by":"crossref","first-page":"E1127","DOI":"10.1152\/ajpendo.00187.2003","volume":"285","author":"SJ Vannucci","year":"2003","unstructured":"Vannucci SJ, Simpson IA (2003) Developmental switch in brain nutrient transporter expression in the rat. Am J Physiol Endocrinol Metab 285(5):E1127\u2013E1134","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"9672_CR96","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/1099800408324558","volume":"10","author":"SL Dormire","year":"2009","unstructured":"Dormire SL (2009) The potential role of glucose transport changes in hot flash physiology: a hypothesis. Biol Res Nurs 10(3):241\u2013247","journal-title":"Biol Res Nurs"},{"issue":"1","key":"9672_CR97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/glia.440140107","volume":"14","author":"S Morgello","year":"1995","unstructured":"Morgello S, Uson RR, Schwartz EJ, Haber RS (1995) The human blood-brain barrier glucose transporter (GLUT1) is a glucose transporter of gray matter astrocytes. Glia 14(1):43\u201354","journal-title":"Glia"},{"issue":"1","key":"9672_CR98","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(98)00372-2","volume":"797","author":"S Yu","year":"1998","unstructured":"Yu S, Ding WG (1998) The 45 kDa form of glucose transporter 1 (glut1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain. Brain Res 797(1):65\u201372","journal-title":"Brain Res"},{"issue":"16","key":"9672_CR99","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1073\/pnas.83.16.5784","volume":"83","author":"MJ Birnbaum","year":"1986","unstructured":"Birnbaum MJ, Haspel HC, Rosen OM (1986) Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci U S A 83(16):5784\u20135788","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9672_CR100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0014-5793(93)80129-I","volume":"324","author":"T Asano","year":"1993","unstructured":"Asano T, Takata K, Katagiri H, Ishihara H, Inukai K, Anai M, Hirano H, Yazaki Y et al (1993) The role of N-glycosylation in the targeting and stability of GLUT1 glucose transporter. FEBS Lett 324(3):258\u2013261","journal-title":"FEBS Lett"},{"issue":"36","key":"9672_CR101","doi-asserted-by":"crossref","first-page":"24632","DOI":"10.1016\/S0021-9258(18)54276-9","volume":"266","author":"T Asano","year":"1991","unstructured":"Asano T, Katagiri H, Takata K, Lin JL, Ishihara H, Inukai K, Tsukuda K, Kikuchi M et al (1991) The role of N-glycosylation of GLUT1 for glucose transport activity. J Biol Chem 266(36):24632\u201324636","journal-title":"J Biol Chem"},{"issue":"3","key":"9672_CR102","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-5793(97)00340-2","volume":"407","author":"R Onetti","year":"1997","unstructured":"Onetti R, Baulida J, Bassols A (1997) Increased glucose transport in ras-transformed fibroblasts: a possible role for N-glycosylation of GLUT1. FEBS Lett 407(3):267\u2013270","journal-title":"FEBS Lett"},{"issue":"3","key":"9672_CR103","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1006\/bbrc.2000.2985","volume":"273","author":"RJ McMahon","year":"2000","unstructured":"McMahon RJ, Hwang JB, Frost SC (2000) Glucose deprivation does not affect GLUT1 targeting in 3T3-L1 adipocytes. Biochem Biophys Res Commun 273(3):859\u2013864","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"9672_CR104","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fasebj.8.13.7926364","volume":"8","author":"F Maher","year":"1994","unstructured":"Maher F, Vannucci SJ, Simpson IA (1994) Glucose transporter proteins in brain. FASEB J 8(13):1003\u20131011","journal-title":"FASEB J"},{"issue":"4","key":"9672_CR105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jnr.490420404","volume":"42","author":"F Maher","year":"1995","unstructured":"Maher F (1995) Immunolocalization of GLUT1 and GLUT3 glucose transporters in primary cultured neurons and glia. J Neurosci Res 42(4):459\u2013469","journal-title":"J Neurosci Res"},{"issue":"4","key":"9672_CR106","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/1044-7431(91)90066-W","volume":"2","author":"F Maher","year":"1991","unstructured":"Maher F, Davies-Hill TM, Lysko PG, Henneberry RC, Simpson IA (1991) Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: evidence for neuron-specific expression of GLUT3. Mol Cell Neurosci 2(4):351\u2013360","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"9672_CR107","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/endo.131.3.1505464","volume":"131","author":"GJ Mantych","year":"1992","unstructured":"Mantych GJ, James DE, Chung HD, Devaskar SU (1992) Cellular localization and characterization of glut3 glucose transporter isoform in human brain. Endocrinology 131(3):1270\u20131278","journal-title":"Endocrinology"},{"issue":"2","key":"9672_CR108","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1073\/pnas.89.2.733","volume":"89","author":"DZ Gerhart","year":"1992","unstructured":"Gerhart DZ, Broderius MA, Borson ND, Drewes LR (1992) Neurons and microvessels express the brain glucose transporter protein glut3. Proc Natl Acad Sci U S A 89(2):733\u2013737","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9672_CR109","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1042\/bj3150827","volume":"315","author":"F Maher","year":"1996","unstructured":"Maher F, Davies-Hill TM, Simpson IA (1996) Substrate specificity and kinetic parameters of glut3 in rat cerebellar granule neurons. Biochem J 315(3):827\u2013831","journal-title":"Biochem J"},{"issue":"11","key":"9672_CR110","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.jcbfm.9600521","volume":"27","author":"IA Simpson","year":"2007","unstructured":"Simpson IA, Carruthers A, Vannucci SJ (2007) Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 27(11):1766\u20131791","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"9672_CR111","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/bj3010379","volume":"301","author":"F Maher","year":"1994","unstructured":"Maher F, Simpson IA (1994) The GLUT3 glucose transporter is the predominant isoform in primary cultured neurons: assessment by biosynthetic and photoaffinity labelling. Biochem J 301(2):379\u2013384","journal-title":"Biochem J"},{"issue":"1","key":"9672_CR112","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C","volume":"21","author":"SJ Vannucci","year":"1997","unstructured":"Vannucci SJ, Maher F, Simpson IA (1997) Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21(1):2\u201321","journal-title":"Glia"},{"issue":"2","key":"9672_CR113","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.1152\/ajpendo.90388.2008","volume":"295","author":"IA Simpson","year":"2008","unstructured":"Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ (2008) The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab 295(2):E242\u2013E253","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"9672_CR114","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/nn.3510","volume":"16","author":"WA Flavahan","year":"2013","unstructured":"Flavahan WA, Wu Q, Hitomi M, Rahim N, Kim Y, Sloan AE, Weil RJ, Nakano I et al (2013) Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat Neurosci 16(10):1373\u20131382","journal-title":"Nat Neurosci"},{"issue":"7573","key":"9672_CR115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature14655","volume":"526","author":"D Deng","year":"2015","unstructured":"Deng D, Sun P, Yan C, Ke M, Jiang X, Xiong L, Ren W, Hirata K et al (2015) Molecular basis of ligand recognition and transport by glucose transporters. Nature 526(7573):391\u2013396","journal-title":"Nature"},{"issue":"3","key":"9672_CR116","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/(SICI)1098-1136(199711)21:3<327::AID-GLIA7>3.0.CO;2-1","volume":"21","author":"J Payne","year":"1997","unstructured":"Payne J, Maher F, Simpson I, Mattice L, Davies P (1997) Glucose transporter glut 5 expression in microglial cells. Glia 21(3):327\u2013331","journal-title":"Glia"},{"issue":"2","key":"9672_CR117","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00401-002-0627-4","volume":"105","author":"Y Horikoshi","year":"2003","unstructured":"Horikoshi Y, Sasaki A, Taguchi N, Maeda M, Tsukagoshi H, Sato K, Yamaguchi H (2003) Human GLUT5 immunolabeling is useful for evaluating microglial status in neuropathological study using paraffin sections. Acta Neuropathol 105(2):157\u2013162","journal-title":"Acta Neuropathol"},{"issue":"1","key":"9672_CR118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/endo.132.1.8419132","volume":"132","author":"GJ Mantych","year":"1993","unstructured":"Mantych GJ, James DE, Devaskar SU (1993) Jejunal\/kidney glucose transporter isoform (Glut-5) is expressed in the human blood-brain barrier. Endocrinology 132(1):35\u201340","journal-title":"Endocrinology"},{"issue":"21","key":"9672_CR119","doi-asserted-by":"crossref","first-page":"14523","DOI":"10.1016\/S0021-9258(18)42067-4","volume":"267","author":"CF Burant","year":"1992","unstructured":"Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO (1992) Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 267(21):14523\u201314526","journal-title":"J Biol Chem"},{"issue":"2","key":"9672_CR120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/bbrc.1997.7204","volume":"238","author":"S Kane","year":"1997","unstructured":"Kane S, Seatter MJ, Gould GW (1997) Functional studies of human GLUT5: effect of pH on substrate selection and an analysis of substrate interactions. Biochem Biophys Res Commun 238(2):503\u2013505","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"9672_CR121","doi-asserted-by":"crossref","first-page":"E227","DOI":"10.1152\/ajpendo.90245.2008","volume":"295","author":"V Douard","year":"2008","unstructured":"Douard V, Ferraris RP (2008) Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metab 295(2):E227\u2013E237","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"9672_CR122","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1074\/jbc.M808128200","volume":"284","author":"S Barone","year":"2009","unstructured":"Barone S, Fussell SL, Singh AK, Lucas F, Xu J, Kim C, Wu X, Yu Y et al (2009) Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J Biol Chem 284(8):5056\u20135066","journal-title":"J Biol Chem"},{"issue":"7573","key":"9672_CR123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature14909","volume":"526","author":"N Nomura","year":"2015","unstructured":"Nomura N, Verdon G, Kang HJ, Shimamura T, Nomura Y, Sonoda Y, Hussien SA, Qureshi AA et al (2015) Structure and mechanism of the mammalian fructose transporter GLUT5. Nature 526(7573):397\u2013401","journal-title":"Nature"},{"issue":"1\u20132","key":"9672_CR124","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(94)90653-X","volume":"638","author":"C Leloup","year":"1994","unstructured":"Leloup C, Arluison M, Lepetit N, Cartier N, Marfaing-Jallat P, Ferre P, Penicaud L (1994) Glucose transporter 2 (GLUT 2): expression in specific brain nuclei. Brain Res 638(1\u20132):221\u2013226","journal-title":"Brain Res"},{"key":"9672_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.06.007","author":"C Leloup","year":"2015","unstructured":"Leloup C, Allard C, Carneiro L, Fioramonti X, Collins S, P\u00e9nicaud L (2015) Glucose and hypothalamic astrocytes: more than a fueling role? Neuroscience. doi: 10.1016\/j.neuroscience.2015.06.007","journal-title":"Neuroscience"},{"issue":"3","key":"9672_CR126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jchemneu.2004.05.009","volume":"28","author":"M Arluison","year":"2004","unstructured":"Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain\u2013an immunohistochemical study. J Chem Neuroanat 28(3):117\u2013136","journal-title":"J Chem Neuroanat"},{"issue":"3","key":"9672_CR127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchemneu.2004.06.002","volume":"28","author":"M Arluison","year":"2004","unstructured":"Arluison M, Quignon M, Thorens B, Leloup C, Penicaud L (2004) Immunocytochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II. Electron microscopic study. J Chem Neuroanat 28(3):137\u2013146","journal-title":"J Chem Neuroanat"},{"issue":"1","key":"9672_CR128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4149\/endo_2014_01_35","volume":"48","author":"J Jurcovicova","year":"2014","unstructured":"Jurcovicova J (2014) Glucose transport in brain\u2013effect of inflammation. Endocr Regul 48(1):35\u201348","journal-title":"Endocr Regul"},{"issue":"1","key":"9672_CR129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jcbfm.2014.171","volume":"35","author":"R Mar\u00edn-Juez","year":"2015","unstructured":"Mar\u00edn-Juez R, Rovira M, Crespo D, van der Vaart M, Spaink HP, Planas JV (2015) GLUT2-mediated glucose uptake and availability are required for embryonic brain development in zebrafish. J Cereb Blood Flow Metab 35(1):74\u201385","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5\u20136","key":"9672_CR130","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000111429","volume":"18","author":"R Forsyth","year":"1996","unstructured":"Forsyth R, Fray A, Boutelle M, Fillenz M, Middleditch C, Burchell A (1996) A role for astrocytes in glucose delivery to neurons? Dev Neurosci 18(5\u20136):360\u2013370","journal-title":"Dev Neurosci"},{"issue":"2","key":"9672_CR131","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0006-8993(96)01122-5","volume":"744","author":"AL McCall","year":"1997","unstructured":"McCall AL, van Bueren AM, Huang L, Stenbit A, Celnik E, Charron MJ (1997) Forebrain endothelium expresses GLUT4, the insulin-responsive glucose transporter. Brain Res 744(2):318\u2013326","journal-title":"Brain Res"},{"issue":"1","key":"9672_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(01)02184-9","volume":"900","author":"C Ngarmukos","year":"2001","unstructured":"Ngarmukos C, Baur EL, Kumagai AK (2001) Co-localization of glut1 and glut4 in the blood-brain barrier of the rat ventromedial hypothalamus. Brain Res 900(1):1\u20138","journal-title":"Brain Res"},{"issue":"2","key":"9672_CR133","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3940(96)12845-7","volume":"213","author":"M Kobayashi","year":"1996","unstructured":"Kobayashi M, Nikami H, Morimatsu M, Saito M (1996) Expression and localization of insulin-regulatable glucose transporter (glut4) in rat brain. Neurosci Lett 213(2):103\u2013106","journal-title":"Neurosci Lett"},{"issue":"4","key":"9672_CR134","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X","volume":"399","author":"S Messari El","year":"1998","unstructured":"El Messari S, Leloup C, Quignon M, Brisorgueil MJ, Penicaud L, Arluison M (1998) Immunocytochemical localization of the insulin-responsive glucose transporter 4 (glut4) in the rat central nervous system. J Comp Neurol 399(4):492\u2013512","journal-title":"J Comp Neurol"},{"issue":"5","key":"9672_CR135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X","volume":"57","author":"J Apelt","year":"1999","unstructured":"Apelt J, Mehlhorn G, Schliebs R (1999) Insulin-sensitive glut4 glucose transporters are colocalized with glut3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J Neurosci Res 57(5):693\u2013705","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"9672_CR136","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0006-8993(02)02308-9","volume":"932","author":"LP Reagan","year":"2002","unstructured":"Reagan LP, Rosell DR, Alves SE, Hoskin EK, McCall AL, Charron MJ, McEwen BS (2002) Glut8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus. Brain Res 932(1\u20132):129\u2013134","journal-title":"Brain Res"},{"issue":"2","key":"9672_CR137","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-328X(02)00487-4","volume":"107","author":"R Sankar","year":"2002","unstructured":"Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU (2002) Insulin-responsive glucose transporters-glut8 and glut4 are expressed in the developing mammalian brain. Brain Res Mol Brain Res 107(2):157\u2013165","journal-title":"Brain Res Mol Brain Res"},{"issue":"4","key":"9672_CR138","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1469-7580.2011.01410.x","volume":"219","author":"O Gomez","year":"2011","unstructured":"Gomez O, Ballester-Lurbe B, Mesonero JE, Terrado J (2011) Glucose transporters glut4 and glut8 are upregulated after facial nerve axotomy in adult mice. J Anat 219(4):525\u2013530","journal-title":"J Anat"},{"issue":"4","key":"9672_CR139","doi-asserted-by":"crossref","first-page":"E614","DOI":"10.1152\/ajpendo.91019.2008","volume":"296","author":"S Schmidt","year":"2009","unstructured":"Schmidt S, Joost HG, Sch\u00fcrmann A (2009) GLUT8, the enigmatic intracellular hexose transporter. Am J Physiol Endocrinol Metab 296(4):E614\u2013E618","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"9672_CR140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1042\/bj3500771","volume":"350","author":"H Doege","year":"2000","unstructured":"Doege H, Bocianski A, Joost HG, Sch\u00fcrmann A (2000) Activity and genomic organization of human glucose transporter 9 (GLUT9), a novel member of the family of sugar-transport facilitators predominantly expressed in brain and leucocytes. Biochem J 350(3):771\u2013776","journal-title":"Biochem J"},{"key":"9672_CR141","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2011.02.014","volume":"1384","author":"CA Stuart","year":"2011","unstructured":"Stuart CA, Ross IR, Howell ME, McCurry MP, Wood TG, Ceci JD, Kennel SJ, Wall J (2011) Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. Brain Res 1384:15\u201322","journal-title":"Brain Res"},{"issue":"1","key":"9672_CR142","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0168-0102(95)00876-U","volume":"22","author":"T Nishizaki","year":"1995","unstructured":"Nishizaki T, Kammesheidt A, Sumikawa K, Asada T, Okada Y (1995) A sodium- and energy-dependent glucose transporter with similarities to sglt1-2 is expressed in bovine cortical vessels. Neurosci Res 22(1):13\u201322","journal-title":"Neurosci Res"},{"issue":"4","key":"9672_CR143","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.STR.29.4.844","volume":"29","author":"T Nishizaki","year":"1998","unstructured":"Nishizaki T, Matsuoka T (1998) Low glucose enhances Na+\/glucose transport in bovine brain artery endothelial cells. Stroke 29(4):844\u2013849","journal-title":"Stroke"},{"issue":"3","key":"9672_CR144","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00418-004-0633-9","volume":"121","author":"K Elfeber","year":"2004","unstructured":"Elfeber K, K\u00f6hler A, Lutzenburg M, Osswald C, Galla HJ, Witte OW, Koepsell H (2004) Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier. Histochem Cell Biol 121(3):201\u2013207","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"9672_CR145","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.108.146589","volume":"328","author":"S Vemula","year":"2009","unstructured":"Vemula S, Roder KE, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ (2009) A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharmacol Exp Ther 328(2):487\u2013495","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9672_CR146","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1471-4159.1997.69010084.x","volume":"69","author":"R Poppe","year":"1997","unstructured":"Poppe R, Karbach U, Gambaryan S, Wiesinger H, Lutzenburg M, Kraemer M, Witte OW, Koepsell H (1997) Expression of the Na+-D-glucose cotransporter SGLT1 in neurons. J Neurochem 69(1):84\u201394","journal-title":"J Neurochem"},{"issue":"12","key":"9672_CR147","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.2337\/db06-0531","volume":"55","author":"D O'Malley","year":"2006","unstructured":"O'Malley D, Reimann F, Simpson AK, Gribble FM (2006) Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 55(12):3381\u20133386","journal-title":"Diabetes"},{"issue":"3","key":"9672_CR148","doi-asserted-by":"crossref","first-page":"C240","DOI":"10.1152\/ajpcell.00317.2012","volume":"304","author":"AS Yu","year":"2013","unstructured":"Yu AS, Hirayama BA, Timbol G, Liu J, Diez-Sampedro A, Kepe V, Satyamurthy N, Huang SC et al (2013) Regional distribution of SGLT activity in rat brain in vivo. Am J Physiol Cell Physiol 304(3):C240\u2013C247","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"9672_CR149","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2006.01746.x","volume":"261","author":"EM Wright","year":"2007","unstructured":"Wright EM, Hirayama BA, Loo DF (2007) Active sugar transport in health and disease. J Intern Med 261(1):32\u201343","journal-title":"J Intern Med"},{"issue":"6","key":"9672_CR150","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/S0006-3495(95)80110-4","volume":"69","author":"XZ Chen","year":"1995","unstructured":"Chen XZ, Coady MJ, Jackson F, Berteloot A, Lapointe JY (1995) Thermodynamic determination of the Na+: glucose coupling ratio for the human SGLT1 cotransporter. Biophys J 69(6):2405\u20132414","journal-title":"Biophys J"},{"issue":"2","key":"9672_CR151","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002329900347","volume":"162","author":"B Mackenzie","year":"1998","unstructured":"Mackenzie B, Loo DD, Wright EM (1998) Relationships between Na+\/glucose cotransporter (SGLT1) currents and fluxes. J Membr Biol 162(2):101\u2013106","journal-title":"J Membr Biol"},{"issue":"5","key":"9672_CR152","doi-asserted-by":"crossref","first-page":"C1552","DOI":"10.1152\/ajpcell.1997.272.5.C1552","volume":"272","author":"WJ Lee","year":"1997","unstructured":"Lee WJ, Peterson DR, Sukowski EJ, Hawkins RA (1997) Glucose transport by isolated plasma membranes of the bovine blood-brain barrier. Am J Physiol 272(5):C1552\u2013C1557","journal-title":"Am J Physiol"},{"issue":"1","key":"9672_CR153","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI116972","volume":"93","author":"Y Kanai","year":"1994","unstructured":"Kanai Y, Lee WS, You G, Brown D, Hediger MA (1994) The human kidney low affinity Na+\/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 93(1):397\u2013404","journal-title":"J Clin Invest"},{"issue":"49","key":"9672_CR154","doi-asserted-by":"crossref","first-page":"29365","DOI":"10.1074\/jbc.270.49.29365","volume":"270","author":"G You","year":"1995","unstructured":"You G, Lee WS, Barros EJ, Kanai Y, Huo TL, Khawaja S, Wells RG, Nigam SK et al (1995) Molecular characteristics of Na+-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem 270(49):29365\u201329371","journal-title":"J Biol Chem"},{"issue":"6","key":"9672_CR155","doi-asserted-by":"crossref","first-page":"C1277","DOI":"10.1152\/ajpcell.00296.2010","volume":"299","author":"AS Yu","year":"2010","unstructured":"Yu AS, Hirayama BA, Timbol G, Liu J, Basarah E, Kepe V, Satyamurthy N, Huang SC et al (2010) Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol 299(6):C1277\u2013C1284","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"9672_CR156","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/diab.44.12.1399","volume":"44","author":"AK Kumagai","year":"1995","unstructured":"Kumagai AK, Kang YS, Boado RJ, Pardridge WM (1995) Upregulation of bloodbrain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 44(12):1399\u20131404","journal-title":"Diabetes"},{"issue":"1","key":"9672_CR157","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1471-4159.1999.0720238.x","volume":"72","author":"IA Simpson","year":"1999","unstructured":"Simpson IA, Appel NM, Hokari M, Oki J, Holman GD, Maher F, Koehler-Stec EM, Vannucci SJ et al (1999) Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 72(1):238\u2013247","journal-title":"J Neurochem"},{"key":"9672_CR158","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2045-8118-11-8","volume":"11","author":"RK Sajja","year":"2014","unstructured":"Sajja RK, Prasad S, Cucullo L (2014) Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC\/D3 cell line. Fluids Barriers CNS 11:8","journal-title":"Fluids Barriers CNS"},{"issue":"4","key":"9672_CR159","first-page":"E716","volume":"272","author":"Y Uehara","year":"1997","unstructured":"Uehara Y, Nipper V, McCall AL (1997) Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons. Am J Physiol 272(4):E716\u2013E719","journal-title":"Am J Physiol"},{"issue":"1","key":"9672_CR160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8227(99)00107-2","volume":"47","author":"DH Lee","year":"2000","unstructured":"Lee DH, Chung MY, Lee JU, Kang DG, Paek YW (2000) Changes of glucose transporters in the cerebral adaptation to hypoglycemia. Diabetes Res Clin Pract 47(1):15\u201323","journal-title":"Diabetes Res Clin Pract"},{"issue":"25\u201326","key":"9672_CR161","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.lfs.2013.10.009","volume":"93","author":"K Sahin","year":"2013","unstructured":"Sahin K, Tuzcu M, Orhan C, Ali S, Sahin N, Gencoglu H, Ozkan Y, Hayirli A et al (2013) Chromium modulates expressions of neuronal plasticity markers and glial fibrillary acidic proteins in hypoglycemia-induced brain injury. Life Sci 93(25\u201326):1039\u20131048","journal-title":"Life Sci"},{"issue":"4","key":"9672_CR162","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11011-015-9659-z","volume":"30","author":"F Zhao","year":"2015","unstructured":"Zhao F, Deng J, Yu X, Li D, Shi H, Zhao Y (2015) Protective effects of vascular endothelial growth factor in cultured brain endothelial cells against hypoglycemia. Metab Brain Dis 30(4):999\u20131007","journal-title":"Metab Brain Dis"},{"key":"9672_CR163","doi-asserted-by":"crossref","unstructured":"(2012) Standards of medical care in diabetes. Diabetes Care 35(1):S11\u2013S63","DOI":"10.2337\/dc12-s011"},{"issue":"9","key":"9672_CR164","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2337\/diab.39.9.1040","volume":"39","author":"WM Pardridge","year":"1990","unstructured":"Pardridge WM, Triguero D, Farrell CR (1990) Downregulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39(9):1040\u20131044","journal-title":"Diabetes"},{"issue":"19","key":"9672_CR165","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1097\/00029330-200710010-00013","volume":"120","author":"WK Hou","year":"2007","unstructured":"Hou WK, Xian YX, Zhang L, Lai H, Hou XG, Xu YX, Yu T, Xu FY et al (2007) Influence of blood glucose on the expression of glucose trans-porter proteins 1 and 3 in the brain of diabetic rats. Chin Med J (Engl) 120(19):1704\u20131709","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"9672_CR166","first-page":"1986","volume":"86","author":"SG Hasselbalch","year":"2001","unstructured":"Hasselbalch SG, Knudsen GM, Capaldo B, Postiglione A, Paulson OB (2001) Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab 86(5):1986\u20131990","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"9672_CR167","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/meta.2002.36347","volume":"51","author":"RJ Jacob","year":"2002","unstructured":"Jacob RJ, Fan X, Evans ML, Dziura J, Sherwin RS (2002) Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: no evidence for protective adaptation by the blood brain barrier. Metabolism 51(12):1522\u20131524","journal-title":"Metabolism"},{"issue":"8","key":"9672_CR168","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.metabol.2005.02.018","volume":"54","author":"ER Seaquist","year":"2005","unstructured":"Seaquist ER, Tkac I, Damberg G, Thomas W, Gruetter R (2005) Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy. Metabolism 54(8):1008\u20131013","journal-title":"Metabolism"},{"key":"9672_CR169","unstructured":"www.alz.org\/downloads\/ facts_Fig.s_2012.pdf"},{"issue":"4","key":"9672_CR170","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64(4):570\u2013575","journal-title":"Arch Neurol"},{"issue":"6","key":"9672_CR171","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metab 7(6):476\u2013484","journal-title":"Cell Metab"},{"issue":"14","key":"9672_CR172","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71(14):1057\u20131064","journal-title":"Neurology"},{"issue":"3","key":"9672_CR173","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2010-091555","volume":"20","author":"DS Knopman","year":"2010","unstructured":"Knopman DS, Roberts R (2010) Vascular risk factors: imaging and neuropathologic correlates. J Alzheimers Dis 20(3):699\u2013709","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"9672_CR174","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1533317509348208","volume":"24","author":"EK Naderali","year":"2009","unstructured":"Naderali EK, Ratcliffe SH, Dale MC (2009) Obesity and Alzheimer's disease: a link between body weight and cognitive function in old age. Am J Alzheimers Dis Other Demen 24(6):445\u2013449","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"2","key":"9672_CR175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.22055","volume":"68","author":"H Dolan","year":"2010","unstructured":"Dolan H, Crain B, Troncoso J, Resnick SM, Zonderman AB, O\u2019brien RJ (2010) Atherosclerosis, dementia, and Alzheimer\u2019s disease in the BLSA cohort. Ann Neurol 68(2):231\u2013240","journal-title":"Ann Neurol"},{"issue":"12","key":"9672_CR176","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1161\/STROKEAHA.111.628156","volume":"42","author":"CK Suemoto","year":"2011","unstructured":"Suemoto CK, Nitrini R, Grinberg LT, Ferretti RE, Farfel JM, Leite RE, Menezes PR, Fregni F et al (2011) Atherosclerosis and dementia: a cross-sectional study with pathological analysis of the carotid arteries. Stroke 42(12):3614\u20133615","journal-title":"Stroke"},{"issue":"5580","key":"9672_CR177","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297(5580):353\u2013356","journal-title":"Science"},{"issue":"9","key":"9672_CR178","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10(9):698\u2013712","journal-title":"Nat Rev Drug Discov"},{"key":"9672_CR179","first-page":"369808","volume":"2012","author":"C Reitz","year":"2012","unstructured":"Reitz C (2012) Alzheimer's disease and the amyloid cascade hypothesis: a critical review. Int J Alzheimers Dis 2012:369808","journal-title":"Int J Alzheimers Dis"},{"issue":"3","key":"9672_CR180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5114\/fn.2014.45562","volume":"52","author":"RA Armstrong","year":"2014","unstructured":"Armstrong RA (2014) A critical analysis of the 'amyloid cascade hypothesis'. Folia Neuropathol 52(3):211\u2013225","journal-title":"Folia Neuropathol"},{"issue":"3","key":"9672_CR181","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jalz.2013.11.003","volume":"10","author":"DA Drachman","year":"2014","unstructured":"Drachman DA (2014) The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimer's disease. Alzheimers Dement 10(3):372\u2013380","journal-title":"Alzheimers Dement"},{"key":"9672_CR182","first-page":"135","volume":"2","author":"GP Morris","year":"2014","unstructured":"Morris GP, Clark IA, Vissel B (2014) Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. Acta Neuropathol Commun 2:135","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"9672_CR183","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration. Trends Neurosci 28(4):202\u2013208","journal-title":"Trends Neurosci"},{"issue":"12","key":"9672_CR184","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm1210-1370","volume":"16","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic BV (2010) Neurodegeneration and the neurovascular unit. Nat Med 16(12):1370\u20131371","journal-title":"Nat Med"},{"issue":"3","key":"9672_CR185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.arr.2010.04.002","volume":"9","author":"JC Torre de la","year":"2010","unstructured":"de la Torre JC (2010) Vascular risk factor detection and control may prevent Alzheimer\u2019s disease. Aging Res Rev 9(3):218\u2013225","journal-title":"Aging Res Rev"},{"issue":"1","key":"9672_CR186","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.11-0102ufm","volume":"25","author":"VT Marchesi","year":"2011","unstructured":"Marchesi VT (2011) Alzheimer\u2019s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25(1):5\u201313","journal-title":"FASEB J"},{"issue":"10","key":"9672_CR187","doi-asserted-by":"crossref","first-page":"a011452","DOI":"10.1101\/cshperspect.a011452","volume":"2","author":"AP Sagare","year":"2012","unstructured":"Sagare AP, Bell RD, Zlokovic BV (2012) Neurovascular dysfunction and faulty amyloid \u03b2-peptide clearance in Alzheimer disease. Cold Spring Harb Perspect Med 2(10):a011452","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"9672_CR188","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205010666131119235254","volume":"11","author":"E Lyros","year":"2014","unstructured":"Lyros E, Bakogiannis C, Liu Y, Fassbender K (2014) Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. Current Alzheimer Res 11(1):18\u201326","journal-title":"Current Alzheimer Res"},{"issue":"5","key":"9672_CR189","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/ana.410290521","volume":"29","author":"SI Harik","year":"1991","unstructured":"Harik SI, LaManna JC (1991) Altered glucose metabolism in microvessels from patients with Alzheimer\u2019s disease. Ann Neurol 29(5):573","journal-title":"Ann Neurol"},{"issue":"7","key":"9672_CR190","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1532-5415.1993.tb07458.x","volume":"41","author":"GS Meneilly","year":"1993","unstructured":"Meneilly GS, Hill A (1993) Alterations in glucose metabolism in patients with Alzheimer\u2019s disease. J Am Geriatr Soc 41(7):710\u2013714","journal-title":"J Am Geriatr Soc"},{"issue":"4\u20135","key":"9672_CR191","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s11064-007-9296-y","volume":"32","author":"G Casadesus","year":"2007","unstructured":"Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA et al (2007) Indices of metabolic dysfunction and oxidative stress. Neurochem Res 32(4\u20135):717\u2013722","journal-title":"Neurochem Res"},{"issue":"2","key":"9672_CR192","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pscychresns.2006.12.003","volume":"155","author":"A Hunt","year":"2007","unstructured":"Hunt A, Schonknecht P, Henze M, Seidl U, Haberkorn U, Schroder J (2007) Reduced cerebral glucose metabolism in patients at risk for Alzheimer\u2019s disease. Psychiatry Res 155(2):147\u2013154","journal-title":"Psychiatry Res"},{"key":"9672_CR193","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","volume":"1147","author":"L Mosconi","year":"2008","unstructured":"Mosconi L, Pupi A, De Leon MJ (2008) Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease. Ann N Y Acad Sci 1147:180\u2013195","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"9672_CR194","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JAD-2011-0066","volume":"26","author":"AJ Furst","year":"2011","unstructured":"Furst AJ, Lal RA (2011) Amyloid-beta and glucose metabolism in Alzheimer\u2019s disease. J Alzheimers Dis 26(3):105\u2013116","journal-title":"J Alzheimers Dis"},{"key":"9672_CR195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C (2013) Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol 108:21\u201343","journal-title":"Prog Neurobiol"},{"issue":"11","key":"9672_CR196","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.39.11.1427","volume":"39","author":"RP Friedland","year":"1989","unstructured":"Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM et al (1989) Regional cerebral glucose transport and utilization in Alzheimer\u2019s disease. Neurology 39(11):1427\u20131434","journal-title":"Neurology"},{"issue":"2","key":"9672_CR197","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/jcbfm.1991.65","volume":"11","author":"WJ Jagust","year":"1991","unstructured":"Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF (1991) Diminished glucose transport in Alzheimer\u2019s disease: dynamic pet studies. J Cereb Blood Flow Metab 11(2):323\u2013330","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"9672_CR198","first-page":"201","volume":"37","author":"M Piert","year":"1996","unstructured":"Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE (1996) Diminished glucose transport and phosphorylation in Alzheimer\u2019s disease determined by dynamic FDG-PET. J Nucl Med 37(2):201\u2013208","journal-title":"J Nucl Med"},{"issue":"10","key":"9672_CR199","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1007\/s00259-007-0454-x","volume":"34","author":"M Samuraki","year":"2007","unstructured":"Samuraki M, Matsunari I, Chen WP, Yajima K, Yanase D, Fujikawa A, Takeda N, Nishimura S et al (2007) Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 34(10):1658\u20131669","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9672_CR200","first-page":"46","volume":"2","author":"F Nobili","year":"2010","unstructured":"Nobili F, Morbelli S (2010) [18F]FDG-PET as a biomarker for early Alzheimer\u2019s disease. Open Nucl Med J 2:46\u201352","journal-title":"Open Nucl Med J"},{"issue":"3","key":"9672_CR201","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-2010-091504","volume":"20","author":"L Mosconi","year":"2010","unstructured":"Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ (2010) Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis 20(3):843\u2013854","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"9672_CR202","first-page":"250","volume":"55","author":"L Mosconi","year":"2011","unstructured":"Mosconi L, McHugh PF (2011) FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging 55(3):250\u2013264","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"11","key":"9672_CR203","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3174\/ajnr.A3695","volume":"35","author":"K Ishii","year":"2014","unstructured":"Ishii K (2014) PET approaches for diagnosis of dementia. AJNR Am J Neuroradiol 35(11):2030\u20132038","journal-title":"AJNR Am J Neuroradiol"},{"key":"9672_CR204","doi-asserted-by":"crossref","first-page":"785039","DOI":"10.1155\/2014\/246586","volume":"2014","author":"D Perani","year":"2014","unstructured":"Perani D, Schillaci O, Padovani A, Nobili FM, Iaccarino L, Della Rosa PA, Frisoni G, Caltagirone C (2014) A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis. Biomed Res Int 2014:785039","journal-title":"Biomed Res Int"},{"issue":"2","key":"9672_CR205","first-page":"143","volume":"4","author":"S Shokouhi","year":"2014","unstructured":"Shokouhi S, Claassen D, Riddle W (2014) Imaging brain metabolism and pathology in Alzheimer's disease with positron emission tomography. J Alzheimers Dis Parkinsonism 4(2):143","journal-title":"J Alzheimers Dis Parkinsonism"},{"issue":"4","key":"9672_CR206","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","volume":"53","author":"RN Kalaria","year":"1989","unstructured":"Kalaria RN, Harik SI (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 53(4):1083\u20131088","journal-title":"J Neurochem"},{"issue":"5","key":"9672_CR207","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410350507","volume":"35","author":"IA Simpson","year":"1994","unstructured":"Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of glut1 and glut3 glucose transporters in the brains of patients with Alzheimer\u2019s disease. Ann Neurol 35(5):546\u2013551","journal-title":"Ann Neurol"},{"issue":"1","key":"9672_CR208","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005072-199501000-00005","volume":"54","author":"SD Harr","year":"1995","unstructured":"Harr SD, Simonian NA, Hyman BT (1995) Functional alterations in Alzheimer\u2019s disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J Neuropathol Exp Neurol 54(1):38\u201341","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"9672_CR209","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0197-4580(97)00111-5","volume":"18","author":"AD Mooradian","year":"1997","unstructured":"Mooradian AD, Chung HC, Shah GN (1997) Glut-1 expression in the cerebra of patients with Alzheimer\u2019s disease. Neurobiol Aging 18(5):469\u2013474","journal-title":"Neurobiol Aging"},{"issue":"5","key":"9672_CR210","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1179\/016164104225016272","volume":"26","author":"TL Bailey","year":"2004","unstructured":"Bailey TL, Rivara CB, Rocher AB, Hof PR (2004) The nature and effects of cortical microvascular pathology in aging and Alzheimer\u2019s disease. Neurol Res 26(5):573\u2013578","journal-title":"Neurol Res"},{"issue":"2","key":"9672_CR211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.febslet.2007.12.035","volume":"582","author":"Y Liu","year":"2008","unstructured":"Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582(2):359\u2013364","journal-title":"FEBS Lett"},{"issue":"8","key":"9672_CR212","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/j.1460-9568.2006.04735.x","volume":"23","author":"X Li","year":"2006","unstructured":"Li X, Lu F, Wang JZ, Gong CX (2006) Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci 23(8):2078\u20132086","journal-title":"Eur J Neurosci"},{"issue":"11","key":"9672_CR213","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1039\/b704905f","volume":"3","author":"WB Dias","year":"2007","unstructured":"Dias WB, Hart GW (2007) O-GlcNAc modification in diabetes and Alzheimer's disease. Mol Biosyst 3(11):766\u2013772","journal-title":"Mol Biosyst"},{"issue":"7","key":"9672_CR214","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","volume":"132","author":"F Liu","year":"2009","unstructured":"Liu F, Shi J, Tanimukai H, Gu J, Gu J, Grundke-Iqbal I, Iqbal K, Gong CX (2009) Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 132(7):1820\u20131832","journal-title":"Brain"},{"issue":"1","key":"9672_CR215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1471-4159.2009.06320.x","volume":"111","author":"Y Liu","year":"2009","unstructured":"Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer\u2019s disease. J Neurochem 111(1):242\u2013249","journal-title":"J Neurochem"},{"issue":"3","key":"9672_CR216","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1567205011310030009","volume":"10","author":"CW Lee","year":"2013","unstructured":"Lee CW, Shih YH, Wu SY, Yang T, Lin C, Kuo YM (2013) Hypoglycemia induces tau hyperphosphorylation. Curr Alzheimer Res 10(3):298\u2013308","journal-title":"Curr Alzheimer Res"},{"issue":"19","key":"9672_CR217","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1039\/C4CS00038B","volume":"43","author":"SA Yuzwa","year":"2014","unstructured":"Yuzwa SA, Vocadlo DJ (2014) O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond. Chem Soc Rev 43(19):6839\u20136858","journal-title":"Chem Soc Rev"},{"issue":"50","key":"9672_CR218","doi-asserted-by":"crossref","first-page":"34472","DOI":"10.1074\/jbc.R114.601351","volume":"289","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Shan X, Yuzwa SA, Vocadlo DJ (2014) The emerging link between O-GlcNAc and Alzheimer disease. J Biol Chem 289(50):34472\u201334481","journal-title":"J Biol Chem"},{"issue":"4","key":"9672_CR219","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","volume":"18","author":"EA Winkler","year":"2015","unstructured":"Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S et al (2015) GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18(4):521\u2013530","journal-title":"Nat Neurosci"},{"issue":"3","key":"9672_CR220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","volume":"71","author":"K Akter","year":"2011","unstructured":"Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB (2011) Diabetes mellitus and Alzheimer\u2019s disease: shared pathology and treatment? Br J Clin Pharmacol 71(3):365\u2013376","journal-title":"Br J Clin Pharmacol"},{"key":"9672_CR221","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2011.12.063","volume":"1441","author":"SC Correia","year":"2012","unstructured":"Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, Oliveira CR, Moreira PI (2012) Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation. Brain Res 1441:64\u201378","journal-title":"Brain Res"},{"issue":"6","key":"9672_CR222","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/15672050113109990009","volume":"10","author":"E Adeghate","year":"2013","unstructured":"Adeghate E, Don\u00e1th T, Adem A (2013) Alzheimer disease and diabetes mellitus: do they have anything in common? Curr Alzheimer Res 10(6):609\u2013617","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"9672_CR223","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s12035-012-8352-z","volume":"47","author":"W Ahmad","year":"2013","unstructured":"Ahmad W (2013) Overlapped metabolic and therapeutic links between Alzheimer and diabetes. Mol Neurobiol 47(1):399\u2013424","journal-title":"Mol Neurobiol"},{"issue":"12","key":"9672_CR224","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/14737175.2013.864824","volume":"13","author":"FG Felice De","year":"2013","unstructured":"De Felice FG (2013) Connecting type 2 diabetes to Alzheimer's disease. Expert Rev Neurother 13(12):1297\u20131299","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"9672_CR225","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11892-014-0476-2","volume":"14","author":"A Jayaraman","year":"2014","unstructured":"Jayaraman A, Pike CJ (2014) Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep 14(4):476","journal-title":"Curr Diab Rep"},{"issue":"7","key":"9672_CR226","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2174\/1871527313666140917114537","volume":"13","author":"G Mushtaq","year":"2014","unstructured":"Mushtaq G, Khan JA, Kamal MA (2014) Biological mechanisms linking Alzheimer's disease and type-2 diabetes mellitus. CNS Neurol Disord Drug Targets 13(7):1192\u20131201","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9672_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.04.008","author":"G Verdile","year":"2015","unstructured":"Verdile G, Fuller SJ, Martins RN (2015) The role of type 2 diabetes in neurodegeneration. Neurobiol Dis. doi: 10.1016\/j.nbd.2015.04.008","journal-title":"Neurobiol Dis"},{"issue":"6","key":"9672_CR228","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","volume":"2","author":"SM Monte de la","year":"2008","unstructured":"de la Monte SM, Wands JR (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2(6):1101\u20131113","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"9672_CR229","first-page":"373","volume":"14","author":"Z Kroner","year":"2009","unstructured":"Kroner Z (2009) The relationship between Alzheimer\u2019s disease and diabetes: type 3 diabetes? Altern Med Rev 14(4):373\u2013379","journal-title":"Altern Med Rev"},{"issue":"2","key":"9672_CR230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/rej.2011.1289","volume":"15","author":"G Accardi","year":"2012","unstructured":"Accardi G, Caruso C, Colonna-Romano G, Camarda C, Monastero R, Candore G (2012) Can Alzheimer disease be a form of type 3 diabetes? Rejuvenation Res 15(2):217\u2013221","journal-title":"Rejuvenation Res"},{"issue":"10","key":"9672_CR231","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s10072-015-2352-5","volume":"36","author":"S Ahmed","year":"2015","unstructured":"Ahmed S, Mahmood Z, Zahid S (2015) Linking insulin with Alzheimer's disease: emergence as type III diabetes. Neurol Sci 36(10):1763\u20131769","journal-title":"Neurol Sci"},{"issue":"10","key":"9672_CR232","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.3390\/ijms131012629","volume":"13","author":"K Shah","year":"2012","unstructured":"Shah K, Desilva S, Abbruscato T (2012) The role of glucose transporters in brain disease: diabetes and Alzheimer\u2019s disease. Int J Mol Sci 13(10):12629\u201312655","journal-title":"Int J Mol Sci"},{"key":"9672_CR233","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.apha.2014.06.013","volume":"71","author":"BJ Thompson","year":"2014","unstructured":"Thompson BJ, Ronaldson PT (2014) Drug delivery to the ischemic brain. Adv Pharmacol 71:165\u2013202","journal-title":"Adv Pharmacol"},{"issue":"10","key":"9672_CR234","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2174\/13816128113199990465","volume":"20","author":"K Shah","year":"2014","unstructured":"Shah K, Abbruscato T (2014) The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke. Curr Pharm Des 20(10):1510\u20131522","journal-title":"Curr Pharm Des"},{"key":"9672_CR235","first-page":"e52699","volume":"99","author":"H Alluri","year":"2015","unstructured":"Alluri H, Anasooya Shaji C, Davis ML, Tharakan B (2015) Oxygen-glucose deprivation and reoxygenation as an in vitro ischemia-reperfusion injury model for studying blood-brain barrier dysfunction. J Vis Exp 99:e52699","journal-title":"J Vis Exp"},{"issue":"1","key":"9672_CR236","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00004647-199601000-00008","volume":"16","author":"AL McCall","year":"1996","unstructured":"McCall AL, Van Bueren AM, Nipper V, Moholt-Siebert M, Downes H, Lessov N (1996) Forebrain ischemia increases GLUT1 protein in brain microvessels and parenchyma. J Cereb Blood Flow Metab 16(1):69\u201376","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"9672_CR237","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004647-199601000-00009","volume":"16","author":"SJ Vannucci","year":"1996","unstructured":"Vannucci SJ, Seaman LB, Vannucci RC (1996) Effects of hypoxia-ischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain. J Cereb Blood Flow Metab 16(1):77\u201381","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"9672_CR238","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-3806(98)00021-2","volume":"107","author":"SJ Vannucci","year":"1998","unstructured":"Vannucci SJ, Reinhart R, Maher F, Bondy CA, Lee WH, Vannucci RC, Simpson IA (1998) Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res Dev Brain Res 107(2):255\u2013264","journal-title":"Brain Res Dev Brain Res"},{"issue":"1","key":"9672_CR239","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.107.038851","volume":"73","author":"WL Yeh","year":"2008","unstructured":"Yeh WL, Lin CJ, Fu WM (2008) Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol Pharmacol 73(1):170\u2013177","journal-title":"Mol Pharmacol"},{"issue":"20","key":"9672_CR240","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1074\/jbc.M110.110593","volume":"285","author":"AJ Cura","year":"2010","unstructured":"Cura AJ, Carruthers A (2010) Acute modulation of sugar transport in brain capillary endothelial cell cultures during activation of the metabolic stress pathway. J Biol Chem 285(20):15430\u201315439","journal-title":"J Biol Chem"},{"issue":"17","key":"9672_CR241","first-page":"1996","volume":"122","author":"WW Zhang","year":"2009","unstructured":"Zhang WW, Zhang L, Hou WK, Xu YX, Xu H, Lou FC, Zhang Y, Wang Q (2009) Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J (Engl) 122(17):1996\u20132001","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"9672_CR242","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1152\/ajpregu.00160.2003","volume":"286","author":"A Zovein","year":"2004","unstructured":"Zovein A, Flowers-Ziegler J, Thamotharan S, Shin D, Sankar R, Nguyen K, Gambhir S, Devaskar SU (2004) Postnatal hypoxic-ischemic brain injury alters mechanisms mediating neuronal glucose transport. Am J Physiol Regul Integr Comp Physiol 286(2):R273\u2013R282","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"9672_CR243","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuint.2011.06.006","volume":"59","author":"S Iwabuchi","year":"2011","unstructured":"Iwabuchi S, Kawahara K (2011) Inducible astrocytic glucose transporter-3 contributes to the enhanced storage of intracellular glycogen during reperfusion after ischemia. Neurochem Int 59(2):319\u2013325","journal-title":"Neurochem Int"},{"issue":"4","key":"9672_CR244","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2174\/187152410793429755","volume":"10","author":"M Espinoza-Rojo","year":"2010","unstructured":"Espinoza-Rojo M, Iturralde-Rodr\u00edguez KI, Ch\u00e1nez-C\u00e1rdenas ME, Ruiz-Tachiqu\u00edn ME, Aguilera P (2010) Glucose transporters regulation on ischemic brain: possible role as therapeutic target. Cent Nerv Syst Agents Med Chem 10(4):317\u2013325","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"9672_CR245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuint.2014.03.007","volume":"70","author":"S Zhang","year":"2014","unstructured":"Zhang S, Zuo W, Guo XF, He WB, Chen NH (2014) Cerebral glucose transporter: the possible therapeutic target for ischemic stroke. Neurochem Int 70:22\u201329","journal-title":"Neurochem Int"},{"key":"9672_CR246","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12987-015-0005-y","volume":"12","author":"KK Shah","year":"2015","unstructured":"Shah KK, Boreddy PR, Abbruscato TJ (2015) Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice. Fluids Barriers CNS 12:10","journal-title":"Fluids Barriers CNS"},{"key":"9672_CR247","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2012.10.020","volume":"1489","author":"Y Yamazaki","year":"2012","unstructured":"Yamazaki Y, Harada S, Tokuyama S (2012) Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter. Brain Res 1489:113\u2013120","journal-title":"Brain Res"},{"key":"9672_CR248","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neuroscience.2014.03.046","volume":"269","author":"Y Yamazaki","year":"2014","unstructured":"Yamazaki Y, Harada S, Tokuyama S (2014) Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage. Neuroscience 269:134\u2013142","journal-title":"Neuroscience"},{"key":"9672_CR249","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neulet.2015.08.004","volume":"604","author":"Y Yamazaki","year":"2015","unstructured":"Yamazaki Y, Harada S, Tokuyama S (2015) Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia. Neurosci Lett 604:134\u2013139","journal-title":"Neurosci Lett"},{"issue":"10","key":"9672_CR250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199109053251006","volume":"325","author":"DC Vivo De","year":"1991","unstructured":"De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. New Eng J Med 325(10):703\u2013709","journal-title":"New Eng J Med"},{"issue":"1","key":"9672_CR251","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/hmg\/10.1.63","volume":"10","author":"J Klepper","year":"2001","unstructured":"Klepper J, Willemsen M, Verrips A, Guertsen E, Herrmann R, Kutzick C, Fl\u00f6rcken A, Voit T (2001) Autosomal dominant transmission of GLUT1 deficiency. Hum Mol Genet 10(1):63\u201368","journal-title":"Hum Mol Genet"},{"issue":"5","key":"9672_CR252","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0030-1248264","volume":"40","author":"J Klepper","year":"2009","unstructured":"Klepper J, Scheffer H, Elsaid MF, Kamsteeg EJ, Leferink M, Ben-Omran T (2009) Autosomal recessive inheritance of GLUT1 deficiency syndrome. Neuropediatrics 40(5):207\u2013210","journal-title":"Neuropediatrics"},{"issue":"6","key":"9672_CR253","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ana.22088","volume":"68","author":"M Rotstein","year":"2010","unstructured":"Rotstein M, Engelstad K, Yang H, Wang D, Levy B, Chung WK, De Vivo DC (2010) Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol 68(6):955\u2013958","journal-title":"Ann Neurol"},{"issue":"12","key":"9672_CR254","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/1097-0142(20000615)88:12<2774::AID-CNCR16>3.0.CO;2-I","volume":"88","author":"BY Wang","year":"2000","unstructured":"Wang BY, Kalir T, Sabo E, Sherman DE, Cohen C, Burstein DE (2000) Immunohistochemical staining of GLUT1 in benign, hyperplastic and malignant endometrial epithelia. Cancer 88(12):2774\u20132781","journal-title":"Cancer"},{"issue":"6","key":"9672_CR255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1023\/A:1021238900470","volume":"25","author":"J Klepper","year":"2002","unstructured":"Klepper J, Leiendecker B, Bredahl R, Athanassopoulos S, Heinen F, Gertsen E, Fl\u00f6rcken A, Metz A et al (2002) Introduction of a ketogenic diet in young infants. J Inherit Metab Dis 25(6):449\u2013460","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"9672_CR256","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.braindev.2009.02.008","volume":"31","author":"K Brockmann","year":"2009","unstructured":"Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31(7):545\u2013552","journal-title":"Brain Dev"},{"issue":"10","key":"9672_CR257","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.seizure.2013.07.003","volume":"22","author":"V Giorgis De","year":"2013","unstructured":"De Giorgis V, Veggiotti P (2013) GLUT1 deficiency syndrome 2013: current state of the art. Seizure 22(10):803\u2013811","journal-title":"Seizure"},{"issue":"4","key":"9672_CR258","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11910-013-0342-7","volume":"13","author":"TS Pearson","year":"2013","unstructured":"Pearson TS, Akman C, Hinton VJ, Engelstad K, De Vivo DC (2013) Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 13(4):342","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"9672_CR259","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neurol.2013.09.005","volume":"170","author":"D Gras","year":"2014","unstructured":"Gras D, Roze E, Caillet S, M\u00e9neret A, Doummar D, Billette de Villemeur T, Vidailhet M, Mochel F (2014) GLUT1 deficiency syndrome: an update. Rev Neurol (Paris) 170(2):91\u201399","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"9672_CR260","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00415-014-7240-z","volume":"261","author":"WG Leen","year":"2014","unstructured":"Leen WG, Taher M, Verbeek MM, Kamsteeg EJ, van de Warrenburg BP, Willemsen MA (2014) GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol 261(3):589\u2013599","journal-title":"J Neurol"},{"issue":"5","key":"9672_CR261","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0034-1378130","volume":"45","author":"F Ragona","year":"2014","unstructured":"Ragona F, Matricardi S, Castellotti B, Patrini M, Freri E, Binelli S, Granata T (2014) Refractory absence epilepsy and glut1 deficiency syndrome: a new case report and literature review. Neuropediatrics 45(5):328\u2013332","journal-title":"Neuropediatrics"},{"issue":"3","key":"9672_CR262","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0883073812471718","volume":"29","author":"M Tzadok","year":"2014","unstructured":"Tzadok M, Nissenkorn A, Porper K, Matot I, Marcu S, Anikster Y, Menascu S, Bercovich D et al (2014) The many faces of Glut1 deficiency syndrome. J Child Neurol 29(3):349\u2013359","journal-title":"J Child Neurol"},{"issue":"3","key":"9672_CR263","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.21724","volume":"66","author":"A Suls","year":"2009","unstructured":"Suls A, Mullen SA, Weber YG, Verhaert K, Ceulemans B, Guerrini R, Wuttke TV, Salvo-Vargas A et al (2009) Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 66(3):415\u2013419","journal-title":"Ann Neurol"},{"issue":"5","key":"9672_CR264","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.0b013e3181eb58b4","volume":"75","author":"SA Mullen","year":"2010","unstructured":"Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE (2010) Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 75(5):432\u2013440","journal-title":"Neurology"},{"issue":"12","key":"9672_CR265","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1111\/epi.12007","volume":"53","author":"T Arsov","year":"2012","unstructured":"Arsov T, Mullen SA, Damiano JA, Lawrence KM, Huh LL, Nolan M, Young H, Thouin A et al (2012) Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 53(12):e204\u2013e207","journal-title":"Epilepsia"},{"issue":"5","key":"9672_CR266","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.23702","volume":"72","author":"T Arsov","year":"2012","unstructured":"Arsov T, Mullen SA, Rogers S, Phillips AM, Lawrence KM, Damiano JA, Goldberg-Stern H, Afawi Z et al (2012) Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 72(5):807\u2013815","journal-title":"Ann Neurol"},{"issue":"8","key":"9672_CR267","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1212\/WNL.0b013e318247ff54","volume":"78","author":"P Striano","year":"2012","unstructured":"Striano P, Weber YG, Toliat MR, Schubert J, Leu C, Chaimana R, Baulac S, Guerrero R et al (2012) GLUT1 mutations are a rare cause of familial idiopathic generalized epilepsy. Neurology 78(8):557\u2013562","journal-title":"Neurology"},{"issue":"6","key":"9672_CR268","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1172\/JCI34438","volume":"118","author":"YG Weber","year":"2008","unstructured":"Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C et al (2008) GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 118(6):2157\u20132168","journal-title":"J Clin Invest"},{"issue":"7","key":"9672_CR269","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awn113","volume":"131","author":"A Suls","year":"2008","unstructured":"Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, Kempfle J, Wuttke TV et al (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131(7):1831\u20131844","journal-title":"Brain"},{"issue":"11","key":"9672_CR270","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/mds.22507","volume":"24","author":"SA Schneider","year":"2009","unstructured":"Schneider SA, Paisan-Ruiz C, Garcia-Gorostiaga I, Quinn NP, Weber YG, Lerche H, Hardy J, Bhatia KP (2009) GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord 24(11):1684\u20131688","journal-title":"Mov Disord"},{"issue":"10","key":"9672_CR271","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.0b013e31822e0479","volume":"77","author":"YG Weber","year":"2011","unstructured":"Weber YG, Kamm C, Suls A, Kempfle J, Kotschet K, Sch\u00fcle R, Wuttke TV, Maljevic S et al (2011) Paroxysmal choreoathetosis\/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 77(10):959\u2013964","journal-title":"Neurology"},{"issue":"1","key":"9672_CR272","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpn.2011.09.005","volume":"16","author":"A Verrotti","year":"2012","unstructured":"Verrotti A, D'Egidio C, Agostinelli S, Gobbi G (2012) Glut1 deficiency: when to suspect and how to diagnose? Eur J Paediatr Neurol 16(1):3\u20139","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"9672_CR273","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaneurol.2013.3090","volume":"70","author":"WG Leen","year":"2013","unstructured":"Leen WG, Wevers RA, Kamsteeg EJ, Scheffer H, Verbeek MM, Willemsen MA (2013) Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review. JAMA Neurol 70(11):1440\u20131444","journal-title":"JAMA Neurol"},{"issue":"3","key":"9672_CR274","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C","volume":"13","author":"J Klepper","year":"1999","unstructured":"Klepper J, Garcia-Alvarez M, O'Driscoll KR, Parides MK, Wang D, Ho YY, De Vivo DC (1999) Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J Clin Lab Anal 13(3):116\u2013121","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"9672_CR275","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/ana.22640","volume":"70","author":"H Yang","year":"2011","unstructured":"Yang H, Wang D, Engelstad K, Bagay L, Wei Y, Rotstein M, Aggarwal V, Levy B et al (2011) Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 70(6):996\u20131005","journal-title":"Ann Neurol"},{"key":"9672_CR276","unstructured":"Wang D, Pascual JM, De Vivo D. Glucose transporter type 1 deficiency syndrome. In Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K (eds). GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132015"},{"issue":"4","key":"9672_CR277","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.10311","volume":"52","author":"JM Pascual","year":"2002","unstructured":"Pascual JM, Van Heertum RL, Wang D, Engelstad K, De Vivo DC (2002) Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol 52(4):458\u2013464","journal-title":"Ann Neurol"},{"issue":"3","key":"9672_CR278","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.plefa.2003.07.004","volume":"70","author":"J Klepper","year":"2004","unstructured":"Klepper J, Diefenbach S, Kohlsch\u00fctter A, Voit T (2004) Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome. Prostaglandins Leukot Essent Fatty Acids 70(3):321\u2013327","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"8","key":"9672_CR279","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1528-1167.2008.01833.x","volume":"49","author":"J Klepper","year":"2008","unstructured":"Klepper J (2008) Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 49(8):46\u201349","journal-title":"Epilepsia"},{"issue":"8","key":"9672_CR280","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0883073813487600","volume":"28","author":"J Klepper","year":"2013","unstructured":"Klepper J, Leiendecker B (2013) Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol 28(8):1045\u20131048","journal-title":"J Child Neurol"},{"issue":"6","key":"9672_CR281","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.nut.2014.01.005","volume":"30","author":"S Bertoli","year":"2014","unstructured":"Bertoli S, Trentani C, Ferraris C, De Giorgis V, Veggiotti P, Tagliabue A (2014) Long-term effects of a ketogenic diet on body composition and bone mineralization in GLUT-1 deficiency syndrome: a case series. Nutrition 30(6):726\u2013728","journal-title":"Nutrition"},{"issue":"5","key":"9672_CR282","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11940-014-0291-8","volume":"16","author":"P Veggiotti","year":"2014","unstructured":"Veggiotti P, De Giorgis V (2014) Dietary treatments and new therapeutic perspective in GLUT1 deficiency syndrome. Curr Treat Options Neurol 16(5):291","journal-title":"Curr Treat Options Neurol"},{"key":"9672_CR283","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/8904_2014_352","volume":"18","author":"A Chenouard","year":"2015","unstructured":"Chenouard A, Vuillaumier-Barrot S, Seta N, Kuster A (2015) A cause of permanent ketosis: GLUT-1 deficiency. JIMD Rep 18:79\u201383","journal-title":"JIMD Rep"},{"issue":"4","key":"9672_CR284","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF02029495","volume":"11","author":"LD Singh","year":"1996","unstructured":"Singh LD, Singh SP, Handa RK, Ehmann S, Snyder AK (1996) Effects of ethanol on GLUT1 protein and gene expression in rat astrocytes. Metab Brain Dis 11(4):343\u2013357","journal-title":"Metab Brain Dis"},{"issue":"6","key":"9672_CR285","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1530-0277.1995.tb00998.x","volume":"19","author":"IC Hu","year":"1995","unstructured":"Hu IC, Singh SP, Snyder AK (1995) Effects of ethanol on glucose transporter expression in cultured hippocampal neurons. Alcohol Clin Exp Res 19(6):1398\u20131402","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"9672_CR286","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1011115809810","volume":"15","author":"RK Handa","year":"2000","unstructured":"Handa RK, DeJoseph MR, Singh LD, Hawkins RA, Singh SP (2000) Glucose transporters and glucose utilization in rat brain after acute ethanol administration. Metab Brain Dis 15(3):211\u2013222","journal-title":"Metab Brain Dis"},{"issue":"3","key":"9672_CR287","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00213-010-2076-4","volume":"214","author":"PM Abdul Muneer","year":"2011","unstructured":"Abdul Muneer PM, Alikunju S, Szlachetka AM, Haorah J (2011) Inhibitory effects of alcohol on glucose transport across the blood-brain barrier leads to neurodegeneration: preventive role of acetyl-L-carnitine. Psychopharmacology (Berlin) 214(3):707\u2013718","journal-title":"Psychopharmacology (Berlin)"},{"issue":"1\u20132","key":"9672_CR288","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(97)01264-X","volume":"782","author":"R Duelli","year":"1998","unstructured":"Duelli R, Staudt R, Gr\u00fcnwald F, Kuschinsky W (1998) Increase of glucose transporter densities (Glut1 and Glut3) during chronic administration of nicotine in rat brain. Brain Res 782(1\u20132):36\u201342","journal-title":"Brain Res"},{"issue":"4","key":"9672_CR289","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neures.2009.04.017","volume":"64","author":"M Canis","year":"2009","unstructured":"Canis M, Mack B, Gires O, Maurer MH, Kuschinsky W, Duembgen L, Duelli R (2009) Increased densities of monocarboxylate transport protein MCT1 after chronic administration of nicotine in rat brain. Neurosci Res 64(4):429\u2013435","journal-title":"Neurosci Res"},{"key":"9672_CR290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1750-1326-6-23","volume":"6","author":"PM Abdul Muneer","year":"2011","unstructured":"Abdul Muneer PM, Alikunju S, Szlachetka AM, Murrin LC, Haorah J (2011) Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction. Mol Neurodegener 6:23","journal-title":"Mol Neurodegener"},{"issue":"4","key":"9672_CR291","doi-asserted-by":"crossref","first-page":"e19258","DOI":"10.1371\/journal.pone.0019258","volume":"6","author":"PM Abdul Muneer","year":"2011","unstructured":"Abdul Muneer PM, Alikunju S, Szlachetka AM, Haorah J (2011) Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine. PLoS One 6(4):e19258","journal-title":"PLoS One"},{"issue":"2\u20133","key":"9672_CR292","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.mam.2012.07.015","volume":"34","author":"M Rask-Andersen","year":"2013","unstructured":"Rask-Andersen M, Masuram S, Fredriksson R, Schi\u00f6th HB (2013) Solute carriers as drug targets: current use, clinical trials and prospective. Mol Asp Med 34(2\u20133):702\u2013710","journal-title":"Mol Asp Med"},{"issue":"2","key":"9672_CR293","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","volume":"3","author":"WM Pardridge","year":"2003","unstructured":"Pardridge WM (2003) Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv 3(2):90\u2013105","journal-title":"Mol Interv"},{"issue":"1","key":"9672_CR294","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MB:30:1:057","volume":"30","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM (2005) Molecular biology of the blood-brain barrier. Mol Biotechnol 30(1):57\u201370","journal-title":"Mol Biotechnol"},{"issue":"1\u20132","key":"9672_CR295","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","volume":"12","author":"WM Pardridge","year":"2007","unstructured":"Pardridge WM (2007) Blood-brain barrier delivery. Drug Discov Today 12(1\u20132):54\u201361","journal-title":"Drug Discov Today"},{"issue":"9","key":"9672_CR296","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s11095-007-9374-5","volume":"24","author":"S Ohtsuki","year":"2007","unstructured":"Ohtsuki S, Terasaki T (2007) Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development. Pharm Res 24(9):1745\u20131758","journal-title":"Pharm Res"},{"issue":"1","key":"9672_CR297","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/0023210-200923010-00003","volume":"23","author":"MM Patel","year":"2009","unstructured":"Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF (2009) Getting into the brain: approaches to enhance brain drug delivery. CNS Drugs 23(1):35\u201358","journal-title":"CNS Drugs"},{"issue":"9","key":"9672_CR298","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.4155\/fmc.09.137","volume":"1","author":"DD Stenehjem","year":"2009","unstructured":"Stenehjem DD, Hartz AM, Bauer B, Anderson GW (2009) Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier. Future Med Chem 1(9):1623\u20131641","journal-title":"Future Med Chem"},{"issue":"10","key":"9672_CR299","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/13816128113199990469","volume":"20","author":"PT Ronaldson","year":"2014","unstructured":"Ronaldson PT (2014) Targeting transporters for CNS drug delivery. Curr Pharm Des 20(10):1419\u20131421","journal-title":"Curr Pharm Des"},{"key":"9672_CR300","first-page":"795","volume":"9","author":"R Alyautdin","year":"2014","unstructured":"Alyautdin R, Khalin I, Nafeeza MI, Haron MH, Kuznetsov D (2014) Nanoscale drug delivery systems and the blood-brain barrier. Int J Nanomedicine 9:795\u2013811","journal-title":"Int J Nanomedicine"},{"issue":"10","key":"9672_CR301","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2174\/13816128113199990458","volume":"20","author":"NH On","year":"2014","unstructured":"On NH, Miller DW (2014) Transporter-based delivery of anticancer drugs to the brain: improving brain penetration by minimizing drug efflux at the blood-brain barrier. Curr Pharm Des 20(10):1499\u20131509","journal-title":"Curr Pharm Des"},{"issue":"15","key":"9672_CR302","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.bmc.2015.06.022","volume":"23","author":"T Tashima","year":"2015","unstructured":"Tashima T (2015) Intriguing possibilities and beneficial aspects of transporter-conscious drug design. Bioorg Med Chem 23(15):4119\u20134131","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"9672_CR303","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1517\/14728222.2015.1042364","volume":"19","author":"WM Pardridge","year":"2015","unstructured":"Pardridge WM (2015) Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery. Expert Opin Ther Targets 19(8):1059\u20131072","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"9672_CR304","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14712598.1.2.159","volume":"1","author":"C Yang","year":"2001","unstructured":"Yang C, Tirucherai GS, Mitra AK (2001) Prodrug based optimal drug delivery via membrane transporter\/receptor. Expert Opin Biol Ther 1(2):159\u2013175","journal-title":"Expert Opin Biol Ther"},{"key":"9672_CR305","first-page":"155","volume":"61","author":"K Prokai-Tatrai","year":"2003","unstructured":"Prokai-Tatrai K, Prokai L (2003) Modifying peptide properties by prodrug design for enhanced transport into the CNS. Prog Drug Res 61:155\u2013188","journal-title":"Prog Drug Res"},{"issue":"7","key":"9672_CR306","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","volume":"59","author":"VJ Stella","year":"2007","unstructured":"Stella VJ, Nti-Addae KW (2007) Prodrug strategies to overcome poor water solubility. Adv Drug Deliv Rev 59(7):677\u2013694","journal-title":"Adv Drug Deliv Rev"},{"issue":"18","key":"9672_CR307","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2174\/156802611797183230","volume":"11","author":"KM Huttunen","year":"2011","unstructured":"Huttunen KM, Rautio J (2011) Prodrugs\u2013an efficient way to breach delivery and targeting barriers. Curr Top Med Chem 11(18):2265\u20132287","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"9672_CR308","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/molecules13051035","volume":"13","author":"B Pavan","year":"2008","unstructured":"Pavan B, Dalpiaz A, Ciliberti N, Biondi C, Manfredini S, Vertuani S (2008) Progress in drug delivery to the central nervous system by the prodrug approach. Molecules 13(5):1035\u20131065","journal-title":"Molecules"},{"issue":"32","key":"9672_CR309","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.2174\/138161211798194486","volume":"17","author":"B Pavan","year":"2011","unstructured":"Pavan B, Dalpiaz A (2011) Prodrugs and endogenous transporters: are they suitable tools for drug targeting into the central nervous system? Curr Pharm Des 17(32):3560\u20133576","journal-title":"Curr Pharm Des"},{"issue":"10","key":"9672_CR310","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11095-012-0966-3","volume":"30","author":"L Peura","year":"2013","unstructured":"Peura L, Malmioja K, Huttunen K, Lepp\u00e4nen J, H\u00e4m\u00e4l\u00e4inen M, Forsberg MM, Gynther M, Rautio J et al (2013) Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine. Pharm Res 30(10):2523\u20132537","journal-title":"Pharm Res"},{"issue":"11","key":"9672_CR311","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D","volume":"89","author":"I Tamai","year":"2000","unstructured":"Tamai I, Tsuji A (2000) Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 89(11):1371\u20131388","journal-title":"J Pharm Sci"},{"issue":"3\u20134","key":"9672_CR312","first-page":"175","volume":"43","author":"X Guo","year":"2005","unstructured":"Guo X, Geng M, Du G (2005) Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet 43(3\u20134):175\u2013187","journal-title":"Biochem Genet"},{"issue":"2\u20133","key":"9672_CR313","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0014-2999(96)00796-0","volume":"318","author":"T Halmos","year":"1996","unstructured":"Halmos T, Santarromana M, Antonakis K, Scherman D (1996) Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter. Eur J Pharmacol 318(2\u20133):477\u2013484","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"9672_CR314","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-6215(96)00328-X","volume":"299","author":"T Halmos","year":"1997","unstructured":"Halmos T, Santarromana M, Antonakis K, Scherman D (1997) Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted drug delivery to the brain. Evaluation of their interaction with the human erythrocyte GLUT1 hexose transporter. Carbohydr Res 299(1\u20132):15\u201321","journal-title":"Carbohydr Res"},{"issue":"13","key":"9672_CR315","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1021\/jm000077y","volume":"43","author":"EJ Bilsky","year":"2000","unstructured":"Bilsky EJ, Egleton RD, Mitchell SA, Palian MM, Davis P, Huber JD, Jones H, Yamamura HI et al (2000) Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability. J Med Chem 43(13):2586\u20132590","journal-title":"J Med Chem"},{"issue":"15","key":"9672_CR316","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.91.15.7114","volume":"91","author":"R Polt","year":"1994","unstructured":"Polt R, Porreca F, Szab\u00f2 LZ, Bilsky EJ, Davis P, Abbruscato TJ, Davis TP, Harvath R et al (1994) Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc Natl Acad Sci U S A 91(15):7114\u20137118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9672_CR317","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/jpet.104.069393","volume":"311","author":"NO Elmagbari","year":"2004","unstructured":"Elmagbari NO, Egleton RD, Palian MM, Lowery JJ, Schmid WR, Davis P, Navratilova E, Dhanasekaran M et al (2004) Antinociceptive structure-activity studies with enkephalin-based opioid glycopeptides. J Pharmacol Exp Ther 311(1):290\u2013297","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"9672_CR318","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(00)01962-4","volume":"860","author":"G Battaglia","year":"2000","unstructured":"Battaglia G, La Russa M, Bruno V, Arenare L, Ippolito R, Copani A, Bonina F, Nicoletti F (2000) Systematically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents. Brain Res 860(1\u20132):149\u2013156","journal-title":"Brain Res"},{"issue":"1\u20132","key":"9672_CR319","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(00)00421-X","volume":"202","author":"F Bonina","year":"2000","unstructured":"Bonina F, Arenare L, Ippolito R, Boatto G, Battaglia G, Bruno V, de Caparariis P (2000) Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs. Int J Pharm 202(1\u20132):79\u201388","journal-title":"Int J Pharm"},{"issue":"1","key":"9672_CR320","first-page":"25","volume":"11","author":"F Bonina","year":"2003","unstructured":"Bonina F, Puglia C, Rimoli MG, Melisi D, Boatto G, Nieddu M, Malignano A, La Rana G et al (2003) Glycosyl derivatives of dopamine and L-dopa as antiparkinson prodrugs: synthesis, pharmacological activity and in vitro stability studies. J Drug Target 11(1):25\u201336","journal-title":"J Drug Target"},{"issue":"1","key":"9672_CR321","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijpharm.2006.11.051","volume":"336","author":"A Dalpiaz","year":"2007","unstructured":"Dalpiaz A, Filosa R, de Caprariis P, Conte G, Bortolotti F, Biondi C, Scatturin A, Prasad PD et al (2007) Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. Int J Pharm 336(1):133\u2013139","journal-title":"Int J Pharm"},{"issue":"10","key":"9672_CR322","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1021\/jm8015409","volume":"52","author":"M Gynther","year":"2009","unstructured":"Gynther M, Ropponen J, Laine K, Lepp\u00e4nen J, Haapakoski P, Peura L, J\u00e4rvinen T, Rautio J (2009) Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats. J Med Chem 52(10):3348\u20133353","journal-title":"J Med Chem"},{"issue":"4","key":"9672_CR323","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/10611860902795399","volume":"17","author":"Q Chen","year":"2009","unstructured":"Chen Q, Gong T, Liu J, Wang X, Fu H, Zhang Z (2009) Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery. J Drug Target 17(4):318\u2013328","journal-title":"J Drug Target"},{"key":"9672_CR324","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.05.072","volume":"82","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Qu B, Wu X, Li X, Liu Q, Jin X, Guo L, Hai L et al (2014) Design, synthesis and biological evaluation of brain targeting l-ascorbic acid prodrugs of ibuprofen with \"lock-in\" function. Eur J Med Chem 82:314\u2013323","journal-title":"Eur J Med Chem"},{"issue":"8","key":"9672_CR325","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2217\/nnm.12.86","volume":"7","author":"KK Jain","year":"2012","unstructured":"Jain KK (2012) Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (London) 7(8):1225\u20131233","journal-title":"Nanomedicine (London)"},{"issue":"37","key":"9672_CR326","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.2174\/0929867321666140716101921","volume":"21","author":"L Costantino","year":"2014","unstructured":"Costantino L, Boraschi D, Eaton M (2014) Challenges in the design of clinically useful brain-targeted drug nanocarriers. Curr Med Chem 21(37):4227\u20134246","journal-title":"Curr Med Chem"},{"issue":"5","key":"9672_CR327","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.nano.2014.03.001","volume":"10","author":"X Zhou","year":"2014","unstructured":"Zhou X, Porter AL, Robinson DK, Shim MS, Guo Y (2014) Nano-enabled drug delivery: a research profile. Nanomedicine 10(5):889\u2013896","journal-title":"Nanomedicine"},{"issue":"1","key":"9672_CR328","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12272-013-0272-6","volume":"37","author":"SR Hwang","year":"2014","unstructured":"Hwang SR, Kim K (2014) Nano-enabled delivery systems across the blood-brain barrier. Arch Pharm Res 37(1):24\u201330","journal-title":"Arch Pharm Res"},{"issue":"7","key":"9672_CR329","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.nano.2015.06.006","volume":"11","author":"J Ma","year":"2015","unstructured":"Ma J, Porter AL, Aminabhavi TM, Zhu D (2015) Nano-enabled drug delivery systems for brain cancer and Alzheimer's disease: research patterns and opportunities. Nanomedicine 11(7):1763\u20131771","journal-title":"Nanomedicine"},{"issue":"7","key":"9672_CR330","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/10611861003587235","volume":"18","author":"Y Qin","year":"2010","unstructured":"Qin Y, Fan W, Chen H, Yao N, Tang W, Tang J, Yuan W, Kuai R et al (2010) In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes. J Drug Target 18(7):536\u2013549","journal-title":"J Drug Target"},{"issue":"7","key":"9672_CR331","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cclet.2010.12.056","volume":"22","author":"F Lei","year":"2011","unstructured":"Lei F, Fan W, Li XK, Wang S, Hai L, Wu Y (2011) Design, synthesis and preliminary bio-evaluation of glucose-cholesterol derivatives as ligands for brain targeting liposomes. Chin Chem Lett 22(7):831\u2013834","journal-title":"Chin Chem Lett"},{"key":"9672_CR332","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/IJN.S23771","volume":"7","author":"F Xie","year":"2012","unstructured":"Xie F, Yao N, Qin Y, Zhang Q, Chen H, Yuan M, Tang J, Li X et al (2012) Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting. Int J Nanomedicine 7:163\u2013175","journal-title":"Int J Nanomedicine"},{"key":"9672_CR333","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2013.10.007","volume":"72","author":"B Qu","year":"2014","unstructured":"Qu B, Li X, Guan M, Li X, Hai L, Wu Y (2014) Design, synthesis and biological evaluation of multivalent glucosides with high affinity as ligands for brain targeting liposomes. Eur J Med Chem 72:110\u2013118","journal-title":"Eur J Med Chem"},{"issue":"3","key":"9672_CR334","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2012.12.020","volume":"84","author":"ZF Hao","year":"2013","unstructured":"Hao ZF, Cui YX, Li MH, Du D, Liu MF, Tao HQ, Li S, Cao FY et al (2013) Liposomes modified with P-aminophenyl-\u03b1-D-mannopyranoside: a carrier for targeting cerebral functional regions in mice. Eur J Pharm Biopharm 84(3):505\u2013516","journal-title":"Eur J Pharm Biopharm"},{"key":"9672_CR335","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2014.03.006","volume":"182","author":"D Du","year":"2014","unstructured":"Du D, Chang N, Sun S, Li M, Yu H, Liu M, Liu X, Wang G et al (2014) The role of glucose transporters in the distribution of p-aminophenyl-\u03b1-d-mannopyranoside modified liposomes within mice brain. J Control Release 182:99\u2013110","journal-title":"J Control Release"},{"key":"9672_CR336","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.2147\/DDDT.S87906","volume":"9","author":"AS Zidan","year":"2015","unstructured":"Zidan AS, Aldawsari H (2015) Ultrasound effects on brain-targeting mannosylated liposomes: in vitro and blood-brain barrier transport investigations. Drug Des Devel Ther 9:3885\u20133898","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"9672_CR337","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/adhm.201400214","volume":"4","author":"K Shao","year":"2015","unstructured":"Shao K, Zhang Y, Ding N, Huang S, Wu J, Li J, Yang C, Leng Q et al (2015) Functionalized nanoscale micelles with brain targeting ability and intercellular microenvironment biosensitivity for anti-intracranial infection applications. Adv Healthc Mater 4(2):291\u2013300","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"9672_CR338","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/nn406285x","volume":"8","author":"K Shao","year":"2014","unstructured":"Shao K, Ding N, Huang S, Ren S, Zhang Y, Kuang Y, Guo Y, Ma H et al (2014) Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. ACS Nano 8(2):1191\u20131203","journal-title":"ACS Nano"},{"issue":"9","key":"9672_CR339","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1021\/am5091462","volume":"7","author":"Y Guo","year":"2015","unstructured":"Guo Y, Zhang Y, Li J, Zhang Y, Lu Y, Jiang X, He X, Ma H et al (2015) Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy. ACS Appl Mater Interfaces 7(9):5444\u20135453","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"9672_CR340","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3109\/1061186X.2014.913052","volume":"22","author":"J Niu","year":"2014","unstructured":"Niu J, Wang A, Ke Z, Zheng Z (2014) Glucose transporter and folic acid receptor-mediated Pluronic P105 polymeric micelles loaded with doxorubicin for brain tumor treating. J Drug Target 22(8):712\u2013723","journal-title":"J Drug Target"},{"issue":"12","key":"9672_CR341","doi-asserted-by":"crossref","first-page":"e81043","DOI":"10.1371\/journal.pone.0081043","volume":"8","author":"R Gromnicova","year":"2013","unstructured":"Gromnicova R, Davies HA, Sreekanthreddy P, Romero IA, Lund T, Roitt IM, Phillips J, Male DK (2013) Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS One 8(12):e81043","journal-title":"PLoS One"},{"issue":"1","key":"9672_CR342","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biomaterials.2013.09.094","volume":"35","author":"X Jiang","year":"2014","unstructured":"Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F, Feng C, Xie Y et al (2014) Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials 35(1):518\u2013529","journal-title":"Biomaterials"},{"issue":"4","key":"9672_CR343","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jps.23022","volume":"101","author":"P Naik","year":"2012","unstructured":"Naik P, Cucullo L (2012) In vitro blood-brain barrier models: current and perspective technologies. J Pharm Sci 101(4):1337\u20131354","journal-title":"J Pharm Sci"},{"issue":"6","key":"9672_CR344","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1469-7580.2002.00064.x","volume":"200","author":"NJ Abbott","year":"2002","unstructured":"Abbott NJ (2002) Astrocyte\u2010endothelial interactions and the blood\u2010brain barrier permeability. J Anat 200(6):629\u2013638","journal-title":"J Anat"},{"issue":"1","key":"9672_CR345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2005.04.054","volume":"1049","author":"FE Parkinson","year":"2005","unstructured":"Parkinson FE, Hacking C (2005) Pericyte abundance affects sucrose permeability in cultures of rat brain microvascular endothelial cells. Brain Res 1049(1):8\u201314","journal-title":"Brain Res"},{"issue":"8","key":"9672_CR346","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1161\/STROKEAHA.114.005427","volume":"45","author":"Y He","year":"2014","unstructured":"He Y, Yao Y, Tsirka SE, Cao Y (2014) Cell-culture models of the blood-brain barrier. Stroke 45(8):2514\u20132526","journal-title":"Stroke"},{"issue":"13","key":"9672_CR347","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","volume":"19","author":"BB Weksler","year":"2005","unstructured":"Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A et al (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19(13):1872\u20131874","journal-title":"FASEB J"},{"issue":"2","key":"9672_CR348","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/cvr\/cvq146","volume":"87","author":"JM Tarbell","year":"2010","unstructured":"Tarbell JM (2010) Shear stress and the endothelial transport barrier. Cardiovasc Res 87(2):320\u2013330","journal-title":"Cardiovasc Res"},{"issue":"12","key":"9672_CR349","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1063\/1.1136909","volume":"53","author":"SR Bussolari","year":"1982","unstructured":"Bussolari SR, Dewey CF Jr, Gimbrone MA Jr (1982) Apparatus for subjecting living cells to fluid shear stress. Rev Sci Instrum 53(12):1851\u20131854","journal-title":"Rev Sci Instrum"},{"issue":"2","key":"9672_CR350","first-page":"481","volume":"17","author":"KA Stanness","year":"1996","unstructured":"Stanness KA, Guatteo E, Janigro D (1996) A dynamic model of the blood-brain barrier \u201cin vitro\u201d. Neurotoxicology 17(2):481\u2013496","journal-title":"Neurotoxicology"},{"issue":"1","key":"9672_CR351","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1461-5347(98)00110-2","volume":"2","author":"D Janigro","year":"1999","unstructured":"Janigro D, Leaman SM, Stanness KA (1999) Dynamic modeling of the blood-brain barrier: a novel tool for studies of drug delivery to the brain. Pharm Sci Technol Today 2(1):7\u201312","journal-title":"Pharm Sci Technol Today"},{"issue":"2","key":"9672_CR352","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(02)03167-0","volume":"951","author":"L Cucullo","year":"2002","unstructured":"Cucullo L, McAllister MS, Kight K, Krizanac-Bengez L, Marroni M, Mayberg MR, Stanness KA, Janigro D (2002) A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier. Brain Res 951(2):243\u2013254","journal-title":"Brain Res"},{"issue":"1","key":"9672_CR353","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.06.027","volume":"1109","author":"S Santaguida","year":"2006","unstructured":"Santaguida S, Janigro D, Hossain M, Oby E, Rapp E, Cucullo L (2006) Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study. Brain Res 1109(1):1\u201313","journal-title":"Brain Res"},{"issue":"2","key":"9672_CR354","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.jcbfm.9600525","volume":"28","author":"L Cucullo","year":"2008","unstructured":"Cucullo L, Couraud PO, Weksler B, Romero IA, Hossain M, Rapp E, Janigro D (2008) Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 28(2):312\u2013328","journal-title":"J Cereb Blood Flow Metab"},{"key":"9672_CR355","unstructured":"Booth R, Kim H (2011) A multi-layered microfluidic device for in vitro bloodbrain barrier permeability studies. In: International conference on miniaturized systems for chemistry and life sciences. Red Hook: Curran Associates, Inc. pp 1388\u20131390"},{"issue":"10","key":"9672_CR356","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1039\/c2lc40094d","volume":"12","author":"R Booth","year":"2012","unstructured":"Booth R, Kim H (2012) Characterization of a microfluidic in vitro model of the blood-brain barrier (\u03bcBBB). Lab Chip 12(10):1784\u20131792","journal-title":"Lab Chip"},{"issue":"6","key":"9672_CR357","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10544-012-9680-5","volume":"14","author":"JH Yeon","year":"2012","unstructured":"Yeon JH, Na D, Choi K, Ryu SW, Choi C, Park JK (2012) Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures. Biomed Microdevices 14(6):1141\u20131148","journal-title":"Biomed Microdevices"},{"issue":"1","key":"9672_CR358","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10544-012-9699-7","volume":"15","author":"LM Griep","year":"2013","unstructured":"Griep LM, Wolbers F, de Wagenaar B, ter Braak PM, Weksler BB, Romero IA, Couraud PO, Vermes I et al (2013) BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 15(1):145\u2013150","journal-title":"Biomed Microdevices"},{"issue":"6","key":"9672_CR359","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1039\/c2lc41208j","volume":"13","author":"B Prabhakarpandian","year":"2013","unstructured":"Prabhakarpandian B, Shen MC, Nichols JB, Mills IR, Sidoryk-Wegrzynowicz M, Aschner M, Pant K (2013) SyM-BBB: a microfluidic blood brain barrier model. Lab Chip 13(6):1093\u20131101","journal-title":"Lab Chip"},{"issue":"11","key":"9672_CR360","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jps.1119","volume":"90","author":"M Gumbleton","year":"2001","unstructured":"Gumbleton M, Audus KL (2001) Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. J Pharm Sci 90(11):1681\u20131698","journal-title":"J Pharm Sci"},{"issue":"1","key":"9672_CR361","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-004-1377-8","volume":"25","author":"MA Deli","year":"2005","unstructured":"Deli MA, Abrah\u00e1m CS, Kataoka Y, Niwa M (2005) Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25(1):59\u2013127","journal-title":"Cell Mol Neurobiol"},{"key":"9672_CR362","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-0-387-30380-2_2","volume-title":"Handbook of neurochemistry and molecular neurobiology (3rd edition)","author":"E Deli","year":"2007","unstructured":"Deli E (2007) Blood\u2013brain barrier models (chapter 2). In: Abel L (ed) Handbook of neurochemistry and molecular neurobiology (3rd edition). Springer, Berlin, pp 29\u201355"},{"issue":"26","key":"9672_CR363","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2174\/138161211797440159","volume":"17","author":"OO Ogunshola","year":"2011","unstructured":"Ogunshola OO (2011) In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr Pharm Des 17(26):2755\u20132761","journal-title":"Curr Pharm Des"},{"issue":"2","key":"9672_CR364","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/157488911795933910","volume":"6","author":"A T\u00f3th","year":"2011","unstructured":"T\u00f3th A, Veszelka S, Nakagawa S, Niwa M, Deli MA (2011) Patented in vitro blood-brain barrier models in CNS drug discovery. Recent Pat CNS Drug Discov 6(2):107\u2013118","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"1","key":"9672_CR365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2011-1828","volume":"71","author":"I Wilhelm","year":"2011","unstructured":"Wilhelm I, Fazakas C, Krizbai IA (2011) In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars) 71(1):113\u2013128","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"1","key":"9672_CR366","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2174\/138920013804545232","volume":"14","author":"R Shawahna","year":"2013","unstructured":"Shawahna R, Decleves X, Scherrmann JM (2013) Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes. Curr Drug Metab 14(1):120\u2013136","journal-title":"Curr Drug Metab"},{"key":"9672_CR367","doi-asserted-by":"crossref","first-page":"13","DOI":"10.13172\/2052-7853-1-2-913","volume":"1","author":"S Shityakov","year":"2013","unstructured":"Shityakov S, Salvador E, F\u00f6rster C (2013) In silico, in vitro and in vivo methods to analyse drug permeation across the blood brain barrier: a critical review. OA Anaesthetics 1:13","journal-title":"OA Anaesthetics"},{"key":"9672_CR368","doi-asserted-by":"crossref","unstructured":"Abbott NJ, Dolman DEM, Yusof SR, Reichel A (2014) In vitro models of CNS barriers. In Drug delivery to the brain. New York: Springer pp 163\u2013197","DOI":"10.1007\/978-1-4614-9105-7_6"},{"issue":"3","key":"9672_CR369","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejpb.2014.03.012","volume":"87","author":"J Bicker","year":"2014","unstructured":"Bicker J, Alves G, Fortuna A, Falc\u00e3o A (2014) Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. Eur J Pharm Biopharm 87(3):409\u2013432","journal-title":"Eur J Pharm Biopharm"},{"key":"9672_CR370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4939-0320-7_34","volume":"1135","author":"CJ Czupalla","year":"2014","unstructured":"Czupalla CJ, Liebner S, Devraj K (2014) In vitro models of the blood-brain barrier. Methods Mol Biol 1135:415\u2013437","journal-title":"Methods Mol Biol"},{"issue":"12","key":"9672_CR371","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1007\/s11095-014-1464-6","volume":"31","author":"CA Palmiotti","year":"2014","unstructured":"Palmiotti CA, Prasad S, Naik P, Abul KM, Sajja RK, Achyuta AH, Cucullo L (2014) In vitro cerebrovascular modeling in the 21st century: current and prospective technologies. Pharm Res 31(12):3229\u20133250","journal-title":"Pharm Res"},{"issue":"7","key":"9672_CR372","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/mp500046f","volume":"11","author":"I Wilhelm","year":"2014","unstructured":"Wilhelm I, Krizbai IA (2014) In vitro models of the blood\u2013brain barrier for the study of drug delivery to the brain. Mol Pharm 11(7):1949\u20131963","journal-title":"Mol Pharm"},{"issue":"9","key":"9672_CR373","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jps.24329","volume":"104","author":"A Wolff","year":"2015","unstructured":"Wolff A, Antfolk M, Brodin B, Tenje M (2015) In vitro blood-brain barrier models\u2013an overview of established models and new microfluidic approaches. J Pharm Sci 104(9):2727\u20132746","journal-title":"J Pharm Sci"},{"issue":"1","key":"9672_CR374","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","volume":"10","author":"B Weksler","year":"2013","unstructured":"Weksler B, Romero IA, Couraud PO (2013) The hCMEC\/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10(1):16","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"9672_CR375","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2008.05730.x","volume":"107","author":"B Poller","year":"2008","unstructured":"Poller B, Gutmann H, Kr\u00e4henb\u00fchl S, Weksler B, Romero I, Couraud PO, Tuffin G, Drewe J et al (2008) The human brain endothelial cell line hCMEC\/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem 107(5):1358\u20131368","journal-title":"J Neurochem"},{"issue":"4","key":"9672_CR376","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/mp900178j","volume":"7","author":"SM Carl","year":"2010","unstructured":"Carl SM, Lindley DJ, Das D, Couraud PO, Weksler BB, Romero I, Mowery SA, Knipp GT (2010) ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood-brain barrier cell line, hCMEC\/D3 [corrected]. Mol Pharm 7(4):1057\u20131068","journal-title":"Mol Pharm"},{"issue":"1","key":"9672_CR377","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2045-8118-10-33","volume":"10","author":"DE Eigenmann","year":"2013","unstructured":"Eigenmann DE, Xue G, Kim KS, Moses AV, Hamburger M, Oufir M (2013) Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies. Fluids Barriers CNS 10(1):33","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"9672_CR378","doi-asserted-by":"crossref","first-page":"e38149","DOI":"10.1371\/journal.pone.0038149","volume":"7","author":"E Urich","year":"2012","unstructured":"Urich E, Lazic SE, Molnos J, Wells I, Freskg\u00e5rd PO (2012) Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models. PLoS One 7(5):e38149","journal-title":"PLoS One"},{"issue":"1","key":"9672_CR379","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/mp3004308","volume":"10","author":"S Ohtsuki","year":"2013","unstructured":"Ohtsuki S, Ikeda C, Uchida Y, Sakamoto Y, Miller F, Glacial F, Decleves X, Scherrmann JM et al (2013) Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model. Mol Pharm 10(1):289\u2013296","journal-title":"Mol Pharm"},{"issue":"9","key":"9672_CR380","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00232-013-9583-2","volume":"246","author":"M Meireles","year":"2013","unstructured":"Meireles M, Martel F, Ara\u00fajo J, Santos-Buelga C, Gonzalez-Manzano S, Due\u00f1as M, de Freitas V, Mateus N et al (2013) Characterization and modulation of glucose uptake in a human blood-brain barrier model. J Membr Biol 246(9):669\u2013677","journal-title":"J Membr Biol"},{"issue":"8","key":"9672_CR381","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nbt.2247","volume":"30","author":"ES Lippmann","year":"2012","unstructured":"Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, Palecek SP, Shusta EV (2012) Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol 30(8):783\u2013791","journal-title":"Nat Biotechnol"},{"issue":"6","key":"9672_CR382","doi-asserted-by":"crossref","first-page":"e99733","DOI":"10.1371\/journal.pone.0099733","volume":"9","author":"R Cecchelli","year":"2014","unstructured":"Cecchelli R, Aday S, Sevin E, Almeida C, Culot M, Dehouck L, Coisne C, Engelhardt B et al (2014) A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells. PLoS One 9(6):e99733","journal-title":"PLoS One"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9672-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9672-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9672-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9672-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T02:14:31Z","timestamp":1748744071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9672-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,22]]},"references-count":382,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9672"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9672-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,22]]}}}